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Resumo: O uso de processos fotoquímicos em química orgânica de 
síntese tem aumentado significativamente nos últimos anos. 
Contudo o uso de reações fotoquímicas ainda é bastante 
limitado. A fotocicloadição [2+2] é uma das reações mais 
conhecidas e utilizadas em síntese orgânica. 
 O anel ciclobutano tem um elevado interesse sintético pois 
para além de estar presente em vários produtos naturais 
também pode ser utilizado como precursor na construção de 
anéis maiores. A fotocicloadição [2+2] de enonas é uma das 
ferramentas possíveis para a síntese de anéis ciclobutano 
com possibilidade de funcionalização posterior, com potencial 
interesse na formação de precursores interessantes em 
química medicinal. 
 O acesso a novos e complexos vectores tricíclicos foi 
alcançado através de reações de fotocicloadição [2+2]. A 
optimização das condições de reação foi conseguida através 
da versatilidade das reações de fotocicloadição [2+2]. 
 Os novos vectores tricíclicos complexos foram funcionalizados 
com o objectivo de obter estruturas compactas com potencial 
actividade biológica.  
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Abstract: The use of photochemistry in synthetic organic chemistry has 
been increasing in the last few years. However the use of 
photochemical processes is still quite limited. [2+2]-
Photocycloaddition is one of the most known and used tool in 
organic synthesis.  
 The cyclobutane moiety is very useful in organic chemistry since 
it is present in several natural products but can also be used as 
precursor of larger rings. The [2+2]-photocycloaddition of enones 
is a way to synthesize cyclobutanes with the possibility of further 
functionalization with potential interest in building blocks for 
medicinal chemistry. 
 Access to novel and complex tricyclic scaffolds was achieved 
using [2+2]-photocycloaddition reactions. Optimization of 
reaction conditions was accomplished displaying the versatility of 
[2+2]-PCA. 
 The new complex scaffolds were further functionalized in order 
to obtain innovative compact modules with potential biological 
activity. 
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1-Introduction 
Light, more precisely sun light, has been part of the daily life of the human 
beings since the beginning of times. The importance of sun light to life is undeniable, 
plays important roles such as providing the right environmental temperature on planet 
Earth, providing food, and playing a role in medicine since ancient times. The 
discovery of fire and electric light are examples of the intense studies around light 
and the attempt of humans to control light. Therefore it is not surprising that over the 
years many have dedicated their efforts to the understanding of physical and 
chemical properties and uses of light. Photochemistry is the branch of chemistry 
dealing with the chemical effects of light (far UV to IR).1 
In nature we can find several photochemical processes; photosynthesis is the 
best known. Photosynthesis is the ability of plants to transform water and carbon 
dioxide into carbohydrates and oxygen in the presence of light. Photochemistry is 
also exploited in our daily life in cosmetic industry (sunscreens), in sustainable 
technologies (solar energy storage) and among other uses are informatics and 
security devices.2 Although nature and technological development have proven that 
photochemistry is a versatile tool in chemistry and material sciences, the use of 
photochemical steps in the synthesis of organic compounds is still quite limited.  
One of the explanations for the low use of photochemistry in organic synthesis 
is the fact that there are a number of photophysical aspects to be considered and 
optimized in order to plan and predict the result of a light-induced synthetic step. 
Photochemistry also requires some appropriate equipment that can discourage the 
interested user.  
When excitation by light occurs the chemistry of the excited singlet and triplet 
state are added to the chemistry of the ground state, what leaves to conclude that 
photochemistry might triple the reactivity options of a molecule. Often molecules in 
different excitation states behave as completely different molecules. The great 
potential of photochemistry lies on the fact that excitation by light achieves what 
ground state chemistry cannot. 
Until the beginning of the 21st century photochemical synthetic steps were 
mainly focused on overcoming stereoselectivity problems in organic synthesis. In the 
beginning of the century the development of highly chemo-, regio-, diastereo- and 
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enantioselective reactions using light excitation, has made chemists realize that 
photochemistry is a fascinating synthetic tool.  
Photochemical reactions can be performed at low temperatures, in the solid or 
liquid state or under gas-phase conditions, with spin-selective direct excitation or 
sensitization, and even multi-photon processes start to enter the synthetic scenery.3 
Production of photoproducts at industrial scale is possible although there is the 
notion that photochemical reactions are unsuitable for scale-up. Vitamin D3 is 
commercially available and is produced at industrial scale using a synthetic 
photochemical step.4,5 
Photochemical reactions result from the absorbance of light by the starting 
material. Some conditions are required for a successful course of the photoreaction: 
 The wavelength of the light source has to fall within the absorption band 
of the reagent. 
 Nothing interferes with the photons before they reach the target 
molecule. 
 Nothing will interfere with the electronic excited states and quench them 
before they react.6 
1.1.1-Historical remarks 
The firsts attempts to relate the color of organic compounds to their molecular 
structure date back to the mid 19th century, when synthetic dyes became one of the 
most important products of the chemical industry. 
Another mark of the modern photochemistry happened in 1866, when the 
Russian chemist Carl Julius von Fritzsche discovered that a concentrated anthracene 
solution exposed to UV radiation would fall from the solution as a precipitate. This 
precipitation happens because the anthracene molecules form dimers by the action 
of UV-light, which are no longer soluble.7 
In 1876 Witt introduced the terms chromophore (a molecular group that carries 
the potential of generating color) and auxochrome (polar substituents that increase 
the depth of color).3 
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Ciamician and SilberErro! Marcador não definido. studied photoreactions of 
carbonyl compounds and observed photoreductions, photopinacolization, 
intramolecular photoaddition, α-and β-cleavage. These studies would later reveal 
fundamental principles such as the concepts of excited singlet and triplet states. 
Platt’s free electron model, Hückel’s molecular orbital theory and Pariser, Parr 
and Peple’s configuration interaction model provided satisfactory models for the 
interpretation of electronic spectra of conjugated molecules.8 
After 1950, T. Föster, M. Kasha, G. Porter, E. Havinga, G. Hammond, H. 
Zimmerman, J. Michl, N. Turro and L. Salem were among the scientists who 
developed the basic concepts for structure reactivity correlations in photochemistry.3 
Paternó and Büchi observed the first cycloadditions of carbonyl compounds 
onto alkenes, the well-known Paternó-Büchi reaction.Erro! Marcador não definido. 
The development of commercially available lasers and electronic equipment 
allowed for real-time detection of primary transient intermediates by flash photolysis. 
Photochemistry thus emerged as the principal science for the study of organic 
chemistry reaction mechanisms in general, because it can be used to generate the 
intermediates that are postulated to intervene in chemical reactions of the ground 
state. 
This brief selection of the history of photochemistry shows that this branch of 
chemistry developed mainly in the latest half of the 20th century. However a lot 
remains to be discovered and studied. Photochemistry has not yet made its path into 
the daily life of the synthetic organic chemistry labs.  
1.1.2-General photochemical considerations  
Electronic states of a molecule and the transitions states between them can be 
illustrated by the Jablonski diagram (Figure 1). The states are arranged by energy 
vertically and horizontally according to the spin multiplicity.  
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Figure 1: Jablonski diagram.6 
 In a photochemical process the molecule is irradiated at a certain wavelength 
which causes its excitation from the ground state (S0) to the singlet state(s) (S1 or 
higher state S2) followed by the intersystem crossing to the triplet state (T1) from 
which the reaction occurs. In order to obtain full conversion and avoid decomposition 
the ideal wavelength of irradiation is the one that provides the minimum of energy 
required for the excitation into S1.  
To determine the wavelength at which we should irradiate a molecule the UV 
spectrum should be measured. From the UV spectrum it is possible to determine the 
wavelength at which the maximum of absorption takes place. If the molecule is 
irradiated at the wavelength of maximum absorption the amount of energy taken up 
by the molecule is so high that it shows a strong tendency of photodecomposition 
rather than following a directed photochemical pathway. The ideal wavelength of 
irradiation would be at longer wavelengths from the maximum of absorption which 
still results in excitation but with lesser input of energy. If we consider the exemplified 
UV spectrum displayed in Figure 2, the ideal wavelength of irradiation is a value 
along the “shoulder” of the absorption curve (along the green box). 
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Figure 2: UV spectrum of an organic compound. The green dashed box represents the ideal 
wavelength of irradiation to perform a photoreaction. 
 From the UV-spectrum it is possible to determine the extinction coefficient (ε). 
This coefficient determines how many moles of molecules absorb energy at the 
particular wavelength and has its higher level in maximum wavelength of absorption. 
The quantum yield ϕ indicates the fraction of excited states that reacts, provided 
that no competitive quenching occurs. It relates the number of molecules that 
undergo a transformation depending on the number of photons absorbed by a 
molecule. 
  
                      
                
 
Regarding to  [2+2]-photocycloaddition reactions the maximum of the quantum yield can 
be one.  
1.1.3-Irradiation apparatus: lamps, photoreactors 
In the present there are several companies which supply lamps as well as 
complete photochemical reactors (light source, power supply and reaction flasks with 
accessories). The complete photoreactor may be a big investment and might not be 
the most convenient solution for a research unit. The most commonly used flasks are 
made of quartz because being transparent to light at a wide spectrum of wavelengths 
(Figure 3). 
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Figure 3:Transparency of different materials according to wavelength of irradiation.9 
The most widely used light sources are mercury vapor arcs. The efficacy of 
conversion into light is low, and the lamp output is dispersed over a range of 
wavelengths and towards all directions, in consequence only a small amount of the 
emitted light is absorbed by the molecules. These lamps are most useful for external 
irradiation. The low-pressure mercury arcs are used for purposes other than 
preparative photochemistry and therefore are by far the cheapest light source. The 
lamp emission can be modified by means of a coating made from a phosphor that 
absorbs the almost monochromatic mercury radiation and emits a range of longer 
wavelengths. 
The low pressure mercury arcs UV lamps have a spectral distribution of irradiance 
density. This means that the radiation emitted by the lamps is not accurate one value, 
but an interval of wavelengths of irradiation. Although the UV lamps of 254 nm have 
quite a sharp interval of wavelength of irradiation, higher wavelengths lamps have a 
tendency to have a more broad spectral distribution (Figure 4). 
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Figure 5: Spectral distribution of irradiance density for UV lamps provided by Rayonet®.10 
There are other kinds of light sources that are definitely not as widely used as 
the low pressure mercury arcs, such as LEDs and Xenon arcs. LEDs are reasonably 
effective light sources and are available in a large range of monochromatic emitting 
types. These kinds of systems have developed rapidly in last few years. Having a 
long life and being quite cheap are two of the reasons why they will probably replace 
the mercury arcs as light sources for photoreactions.  
1.1.4-Concentration and Scale 
An external irradiation is often used in small scale photoreactions what is not 
an optimal solution for maximizing the exploitation of the emitted radiation. Relatively 
large scale photochemical reactions must take into consideration this fact and 
achieve optimal light irradiation and mass transfer. A clean reaction is rarely obtained 
with a concentration above 0.01-0.1 M.6 
If the reaction product absorbs at the same wavelength as the starting material 
(what commonly occurs) it may hinder the completion of the photoreaction when it is 
photostable (the so called ‘’inner-filter’’ effect) or it may lead to a mixture of primary 
and secondary photoproducts, if the primary product itself is photoreactive. A way of 
minimizing secondary photoreactions is to use lamps with a narrow wavelength range 
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emission, as this may match better the starting material absorption than the primary 
product. 
The effect of impurities on photochemical reactions is relatively small. In order 
to compete for a chemical reaction with the light-driven reaction it must be quite fast, 
because the excited states have a very short life-time. 
1.1.5-Photosensitizers 
The direct excitation of the starting material may not be possible, or may not 
produce the desirable effects on the course of the photoprocess. In these particular 
cases, there is the possibility of using a photosensitizer or a photocatalyst. The 
irradiation of these particular molecules activates them and they will activate the 
starting material by some mechanism (energy transfer, redox step, hydrogen 
abstraction).  
Triplet sensitization is one of the methods used to generate the triplet state of 
molecules that either do not undergo spontaneous ISC following direct excitation or 
undergo unwanted reactions when excited to the singlet state. The triplet energy of 
the donor should exceed that of the acceptor for efficient energy transfer. 
Benzophenone and xanthones are often used as triplet sensitizers, because they 
absorb at relatively long wavelengths, undergo efficient ISC and have a small singlet-
triplet energy gap. Acetone as a solvent is also one the methods of triplet 
sensitization, ensuring that it is responsible by absorbing most of the light.6 
1.1.6-Photochemistry as a “green chemistry” approach 
Photochemical reactions have been described as “green” chemical processes, 
because the driving force in the reaction is simple light irradiation, which is 
considered to be clean energy. 
The role of photochemical processes in sustainable energy sources is 
recognized by the majority of the scientific community. The possibility of replacing the 
fossil fuels by sustainable technology such as solar energy storage with the help of 
photovoltaic cells is one of the most promising technologies. A great effort has been 
made to increase the quality and performance of photovoltaic systems in the last 
decades.  
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1.2-[2+2] Photocycloaditions of enones 
Photochemistry reactions, in particular the [2+2]-photocycloaddition of α,β-
unsaturated carbonyl compounds, known as the de Mayo cycloaddition, has been 
widely explored. The de Mayo cycloaddition is highly stereo- and regioselective.11The 
cycloadducts of cyclic enones are most often cis-fused.12 
Regioselectivity of the de Mayo cycloaddition can be anticipated by analyzing 
electronic properties of the double bonds (Scheme 1).  
O
D
h
A
h
OO
A
D
HH HT
+

3
*
photochemical
reversal of polarity
(umpolung)  
Scheme 1 
Olefins substituted with the so called acceptors substituents (A) originate as a 
major product the head-to-head products. On the contrast olefins substituted with the 
so called donor substituents (D) tend to form preferably the head-to-tail product.6 
Regarding the intramolecular [2+2]-PCA there are important classes of 
products that can be formed (Scheme 2).13 
O
H
O
H
R
R
O
H
H
H
 
Scheme 2 
In general, if possible, a five membered-ring is formed during the 
photochemical step (Scheme 3). 
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Scheme 3 
Photochemical [2+2] cycloadditions can be used to synthetize the cyclobutane 
skeleton. Four membered rings are very versatile in organic chemistry, not only 
because it is a known precursor for natural products and various unique compounds. 
Cyclobutane rings can also undergo ring expansion reactions and originate other size 
rings in di- or tricyclic ring systems.14 
The photochemical cycloadditions of α,β-unsaturated carbonyl, carboxyl, and 
related heterocyclic compounds to alkenes are important synthetic reactions, and the 
mechanisms of such processes have been the subject of controversy ever since the 
firsts reports by Eaton and Corey.15 Cycloaddition occurs in most cases, with 
excitation by light of relatively long wavelengths (λ ≥ 250 nm), after intersystem 
crossing (ISC), from the lowest-lying triplet state (T1), which has often a 
* 
character.16 In an extremely simplified fashion, using a valence bond description, the 
excited state can be written in biradical form (3D), to form the cyclobutane ring 
(Figure 1). 
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Figure 6: Mechanism proposed for the formation of the cyclobutane ring.6 
The energy difference between the S1 and the T1 state of carbonyl compounds 
is low (both are np* states). 
In intramolecular reactions the pattern of substituents in the alkene has large 
influence in the regioselectivity of the reaction, with the general notion being that the 
T1 state shows reverted polarity compared to the ground state.
4 
Most α,β-unsaturated compounds used in [2+2] photocycloadditions reactions 
are cyclic compounds of five- or six-membered rings. This choice avoids the rotation 
around the C-C single bond in intermediate 3D, which would act as rapid decay 
pathway to the ground–state via ultrafast intersystem crossing. The photochemistry 
of enones seems insensitive as to whether the exited enone is obtained by direct 
irradiation or triplet sensitization.15 
There are various types of α,β-unsaturated carbonyl substrates according to 
the type of substituents. In the Figure 7 general structures form A1 to A6 are 
described such as the R represents carbon and hydrogen, while Q represents 
oxygen, nitrogen and sulfur substituents.  
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Figure 7: Types of substrates for [2+2]-photocycloaddition according to the type of 
substituents. 
 According to the different substituents and heteroatoms the wavelength of 
irradiation varies. The presence of sulfur substituents is not widely explored. 
Photochemical enantioselective approaches to chiral molecules have been 
pursued along different lines of research. For a reaction to proceed in an 
enantioselective manner one way can be the use prochiral substrates. However this 
will only work if the photo-precursor has enantiotopic groups or faces that are 
recognized by the chiral entity. Providing a chiral environment in a photochemical 
reaction can be done in several ways, such as the use of homochiral crystals, 
inclusion complexes and chiral complexing agents (Scheme 1). 
C  
Scheme 4: Example of a chiral complexing agent. 
A chiral complexing agent usually binds to the substrate by non-covalent 
interactions, establishing a fast and reversible equilibrium. Most chiral templates have 
motifs capable of establishing hydrogen bonding, and since light does not interfere 
with hydrogen bonds this has been considered a promising approach to 
enantiocontrol of photoreactions (Scheme 2).17  
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Scheme 5: Association behavior of a lactam substrate in the presence of complexing agent 
C 
Photochemistry, and in particular [2+2]-PCA are underestimated tools in 
synthetic organic chemistry. Therefore to prove the versatility and accessibility of the 
[2+2]-PCA in the establishment of the cyclobutane rings in complex moieties is one 
the aims of this work. 
1.3-Compact Modules in Medicinal Chemistry 
Compact modules are essentially novel molecular scaffolds that provide 
access to specific molecular topologies with a set of diverse functional groups. These 
building blocks have been playing important roles in synthetic chemistry in the drug 
discovery processes.  
Medicinal chemistry relies on the generation of new leads that discriminate 
among biological targets, promote selectivity and enhance the safety profile of a drug 
candidate. An ideal compact module is a polyfunctional scaffold with tunable 
polarities that affect physico-chemical and safety parameters in a beneficial way. The 
vectorization of the scaffold plays an important role in the access of a diverse 
collection of derivatives.18 
Despite the fact that cyclobutanes have a three-dimensional vectorised 
topology which is a relevant feature in the core of drug structures their use is far from 
reaching the use of the phenyl group. Even though almost every over-the-counter 
drug possesses one or more phenyl rings, the higher complexity of recent targets is 
requiring a more versatile and arquitectural core.  
One of the main goals of this particular work is the synthesis of innovative and 
complex compact modules containing a cyclobutane ring.  
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Screening compounds generated from such novel scaffolds readily overcome 
the molecular ‘flatness’ (low sp3 character) which has become prevalent in the 
industry in recent years, driven by sp2-sp2 aryl couplings emerging as favored 
synthetic steps. Low alkyl sp3 character in compounds can have a negative effect on 
aqueous solubility and formulation, whilst increased aromaticity can increase 
undesired properties, such as CYP inhibition, plasma-protein binding and hERG 
binding, which negatively impact drug development.19 
1.4. Alzheimer’s disease and BACE1 
In the beginning of the 20th century the German psychiatrist and pathologist 
Alois Alzheimer identified the presence of cellular abnormalities in post-mortem brain 
tissue. The patient had showed progressive memory loss and signs of confusion, 
which Alzheimer attributed to the formation of these abnormal deposits in the brain  
Alzheimer’s disease (AD) has become one of most common chronic 
neurodegenerative diseases and has fast becoming a serious economic and social 
burden. Characterized by memory and brain function loss this disease interferes with 
the ability to perform simple daily tasks. Besides affecting the patient itself this 
degenerative disease has a high impact on the life of the patient’s loved ones. The 
progressive brain degeneration is followed side by side by visible deterioration of the 
patient’s condition.  
AD is a prevalent disease globally with a high unmet medical need. Large 
investments in scientific research have led to the dramatic increase in the 
comprehension of the pathology over the last 20 years. However, due to the 
complexity of the molecular pathways in the brain, the mechanisms causing AD are 
still not fully understood. 
1.4.1-The Amyloid cascade hypothesis  
AD is pathologically characterized by the existence of two types of structures 
in the brain of the patients: extracellular deposits known by amyloid plaques and 
intracellular structures known as neurofibrillary tangles. Both these structures are 
composed by misfolded proteins/peptides that form neurotoxic aggregates.  
Amyloid plaques consist of aggregates of Aβ peptides. These peptides are 
formed by the cleavage of the amyloid precursor protein (APP) on the β-site APP 
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cleaving enzyme (BACE) followed by γ-secretase cleavage. Neurofibrillary tangles 
consist of aggregates of the TAU protein that suffered hyperphosphorylation leading 
to conformational changes that inactivate the protein. Even though the 
hyperphosphorylation of TAU is also a subject of study, deposition of the amyloid β-
peptides in the brain is considered the central event towards Alzheimer’s disease.  
The amyloid cascade hypothesis is based on the accumulation of amyloid-β-
aggregates (Aβ) in the brain that are toxic to neurons. To date the amyloid cascade 
has not been fully validated however, is the most supported theory.  
 
Figure 8: Illustration of the amyloid cascade hypothesis. 
The role of APP peptide in the cell is not fully understood. It is known that in a 
normal person the APP peptides are cleaved by the protease α-secretase, releasing 
sAPPα and a peptide that is a substrate for the γ-secretase that forms P3 and AICD 
(APP intracitoplasmatic domain). These peptides are expected to play roles in cell 
signaling pathways. BACE1 cleaves APP in its β-site leading to the formation of a 
substrate that when cleaved by γ-secretase releases Aβ peptides that tend to 
accumulate in brain tissue (Figure 8).The cleavage of APP by BACE1 also occurs in 
healthy organisms. However, in healthy organisms the clearance of Aβ peptides does 
not allow the accumulation of amyloid. If the clearance mechanisms of Aβ peptides 
stop working properly there is accumulation. There are two isoforms of Aβ: Aβ40 and 
Aβ42. The isoform that is more likely to adopt a fibril conformation and accumulate is 
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Aβ42. In familiar cases of AD is known that there is a genetically guided unbalance of 
the two isoforms in favor of the Aβ42. The presence of more Aβ42 in the cell makes 
the formation of amyloid plaques more favorable. Cases of AD with no genetic 
association usually are caused by the failure of mechanisms of clearance of Aβ 
peptides. 
Through the years several different hypotheses about the role of the amyloid 
pathway have been proposed but none of them was completely validated.20 
Several mutations in APP have been identified. One of the identified mutations 
(on Ala-673) leads to the synthesis of an APP analogue that is a less efficient 
substrate for BACE1. People with this specific mutation have a higher chance to 
achieve the age of 85 years without Alzheimer’s disease as well as slowing the 
natural cognitive decline in the elderly.21 This finding is responsible for reinforcing 
that BACE1 maybe the therapeutic target of choice when developing anti-Alzheimer’s 
drugs.  
Much research has gone into understanding the amyloidogenicity of the Aβ 
peptides. Preventing their formation is considered the most promising way to stop the 
evolution of Alzheimer’s disease. Therefore drugs that might induce dissolution of the 
amyloid aggregates in plaque or inhibit the action of the β-or γ-secretase would be 
desired for Alzheimer’s disease therapy. 
1.4.2-BACE1 as a target in Alzheimer’s disease therapy. 
 The few drugs available on the market for the symptomatic treatment and 
slowing down the progression of AD are targeting the cholinesterase pathway. These 
inhibitors block the breakdown of acetylcholinesterase that is a messenger in 
pathways that regulate memory. These drugs only delay the appearance of 
symptoms without making them regress or stop their progression. Therefore new 
targets to Alzheimer’s disease treatment have to be discovered and explored.  
Through the years several evidences have showed that keeping low levels of 
Aβ peptides is key to prevent the advance of AD.  
BACE1 initiates APP processing in the amyloid pathway, and thus serves as 
rate-limiting step in production of Aβ. This together with the fact that BACE1 
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structural and physiological characteristics are known contributed to the fact that 
BACE1 was rapidly promoted as a prime target in drug discovery. 
BACE1 is the isoform of the β-secretase peptidase expressed in the brain. The 
other isoform BACE2 is expressed in other tissues and plays different roles in the 
organism.  
Validation of BACE1 as a target in Alzheimer’s disease treatment came from 
observations generated from BACE1 knockout mice. The knockout mice also showed 
that complete inhibition of BACE1 might severe side effects like muscular contraction 
atrophy. Therefore only 50% of inhibition is the goal in the drug discovery process. 
BACE1 is a more favorable target than γ-secretase due to the fact that the 
second one is involved in several pathways in the cell being crucial to the formation 
of transcription factors. Inhibition of γ-secretase would lead to more undesirable side 
effects and would require a more challenging and careful regulation mechanisms. 
The aim of this work is the synthesis of novel tricyclic scaffolds that could be 
potentially functionalized to obtain compounds that potentially have activity as 
BACE1 inhibitors. 
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2-[2+2]-Photocycloaddition of 1,3-dioxin-4-ones vs 
1,3-oxathiin-6-ones. 
 
2.1-1,3-Dioxin-4-ones 
1,3-Dioxin-4-ones have been used extensively in synthetic organic chemistry, 
representing ideal substitutes for β-ketocarboxylic acids. The potential use of 1,3-
dioxin-4-ones derivatives as scaffolds in natural product synthesis has been widely 
explored.1  
In the second half of the 20th century the synthesis of 1,3-dioxin-4-ones was 
based on a 1,4-cycloaddition of ketones to acylketenes. In 1983 Sato et al2. reported 
a facile and general synthetic method using β-keto acid derivatives to obtain 1,3-
dioxin-4-ones that have been used until recent times (Scheme 1). 
R
1
= OH or OtBu
1 2
conc. HCl
acetone 
acetic anhydride
 
Scheme 1 
Since the 1980’s 1,3-dioxin-4-ones have been used as substrates in 
photoreactions. The first studies began with the [2+2]-photocycloaddition of 
cyclopentene and cyclohexene to form cyclobutane adducts. Several studies tried to 
propose mechanistic hypotheses to explain and predict the stereochemistry of the 
formed products.3 Various studies led to the conclusion that the facial selectivity 
achieved in the photocycloaddition of 1,3-dioxin-4-ones is opposite to the selectivity 
observed in the ground state reactions, hence the photoaddition tends to occur from 
the apparently most hindered face. To explanain this stereochemical outcome has 
been proposed some explanations that imply the different conformation of the carbon 
atom C-6.4,9 [2+2]-Photocycloaddition of 1,3-dioxin-4-ones leads to the formation a 
new stereogenic center in which diastereofacial control can be achieved. 
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Winkler et al5 used intramolecular [2+2]-PCA of 1,3-dioxin-4-ones in the 
synthesis of several complex natural products. The use of acetone as co-solvent in 
the reaction provided sensitization allowing the access to the product in higher yield. 
In order to develop methods with high stereoselectivity for the synthesis of 
spiro-ketals, Haddad et al.6 used a diastereoselective intramolecular 
photocycloaddition of a chiral 1,3-dioxin-4-one that allowed the generation of four 
stereogenic centers. The dioxinone functionality had several advantages, such as 
providing the required carbon-carbon double bond, enabling the selective 
fragmentation of the produced four-membered ring for further functionalization, 
introducing ketone functionality in the spiro ring, necessary for oxidative enlargement 
for the synthesis of spiro-ketals and allowing asymmetric induction.  
From the 2-tert-butyl-2,6-dimethyl-1,3-dioxin-4-one through an alkylation 
reaction using LDA as the deprotonation agent and the required homoallylic halide it 
is possible to obtain the photoprecursor 3. Irradiation of 3 in a Pyrex filter flask 
(λ>295 nm in MeCN) in the presence of benzophenone as a sensitizer afforded the 
tricyclic isomers 4 and 5 in 92% yield. Haddad and his team reported that the 
temperature at which the reaction was performed had an influence in the facial 
selectivity of the [2+2]-PCA. The increase of the temperature from –70 °C to 0 °C 
caused a decrease in selectivity, however in both cases the major product was 5. 
This shows a preference for the less hindered face of the dioxinone (Scheme 2).6 
3 4 5
hν (λ295 nm)
0.01 eq. Ph
2
CO
MeCN
92%
 
Scheme 2 
Increasing of the chain by one carbon it is possible to form 6-membered rings 
through the intramolecular [2+2]-PCA. Carreira et al.’s O-allyl and O-vinyl dioxinone 
ethers (6 and 9)gave tricyclic ring systems, that under alkaline conditions fragments 
into 2,5-disubstituted tetrahydrofuran-3-ones and 2,5-disubstituted tetrahydropyran-4-
ones – both are common building blocks in natural product synthesis (Scheme 3).7 
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Scheme 3 
More recently in 2005, Winkler et al.8 reported the intramolecular 
photocycloaddition of dioxinones with alkynes leading to the formation of cyclobutene 
adducts, which are unstable under the photochemical reaction conditions and 
afforded secondary photoproducts, whose structure differed by the substituent on the 
alkyne photoprecursor (Scheme 4). 
12 13
14 15
hν (λ295)
11% acetone
in MeCN 
hν (λ>295)
11% acetone
in MeCN 
or
  
Scheme 4 
Given the potential use of 1,3-dioxin-4-ones as new scaffolds for medicinal 
chemistry, the synthesis of novel spiroketals with a tricyclic skeleton seemed the right 
step towards the formation of complex compact modules being interesting for drug 
discovery. 
Since previous studies have shown that lactones of the type A (Scheme 5) 
can be generated by intramolecular [2+2]-photocycloaddition reactions of 
appropriately substituted 4-aminomethyl-2(5H)-furanones, a similar approach to 
synthesize the corresponding 1,3-dioxin-4-ones substrates for the intramolecular 
[2+2]-PCA reaction was used. 
24 
 
 
X=H, F, Me, Ph
TYPE A  
Scheme 5 
6-Bromomethyl-2,2-dimethyl-1,3-dioxin-4-one has been described in the 
literature since the early 1990’s,9 and has been employed in phosphonium salt 
generation reactions,10 substitution with soft carbon nucleophiles,6 and worked as an 
activated β-ketoester in several experiments.11 Despite its easy access there is no 
record of substitution of the bromide with nitrogen nucleophiles. The synthesis of a 
novel photoprecursor combining a 1,3-dioxin-4-one moiety and a pyrrolidine ring was 
planned.  
Although several routes to access compound 17 can be found in the 
literature,12 the one that proved to be the most reliable in our hands started from the 
commercially available 2,2,6-trimethyl-4H-1,3-dioxin-4-one. Through a Wohl-Ziegler 
bromination, exposing a mixture of the substrate 16, NBS and AIBN as a radical 
initiator to sun lamp irradiation, we were able to obtain the 6-bromomethyl-2,2-
dimethyl-1,3-dioxin-4-one in 60% yield. The replacement of CCl4, used in the 
procedure described by Sato et al.,9 by CH2Cl2, allowed a more environmental 
friendly approach without compromising the yield (Scheme 6). 
NBS, AIBN
300 W sunlamp
DCM
reflux, 2.5 h
60%
1716  
Scheme 6 
In order to access the desired photoprecursor nucleophilic substitution with 
allyl amine was performed, followed by Cbz-protection under Schotten-Baumann 
conditions to afford photoprecursor 20a. Regardless of the moderate yields achieved 
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in the bromination and alkylation reactions, this 3-step route allows an easy access to 
the photoprecusor and can be reliably scaled up. To further investigate the influence 
of a different protecting group the photopercursor 20b was also synthetized using a 
standard protocol of amine protection with Boc2O (Scheme 7). 
allyl amine
NEt
3
THF
0-23 °C, 16 h
39%
a) CbzCl
     aq. NaHCO
3
, 
     DCM
     0-23 °C, 18 h
   or
b) Boc
2
O
    THF
    60 °C, 2 h
18
20a- PG=Cbz  78%
20b- PG=Boc  42%
19
 
Scheme 7 
The unique photoprecursors 20a and 20b were successfully synthesized. The 
UV spectrum of 20a was measured as well as the extinction coefficient (ε) 
determined, showing the maximum absorption at 246 nm (ε246 = 8073 M
-1.cm-1). With 
this data in hand it was predicted that irradiation of 20a at 254 nm would lead to a lot 
of uptake of energy, hence short reaction times necessary to avoid large extent of 
photodecomposition (Scheme 8). 
hν
"solvent"
"additives"
20a
(
246
 = 8073 M-1.cm-1)
21a
 
Scheme 8 
Results showed that irradiation at a wavelength of 254 nm for only 1 hour in 
acetonitrile furnished the desired photoproducts in very good yield (Table 1). The Boc 
group proved to be more stable and “photofriendly” than the Cbz group resulting in a 
higher yield (75% (Boc) vs. 57% (Cbz)). This can be rationalized by the presence of 
the π system and the benzylic position in the Cbz protecting group that at high 
energy wavelengths can be excited and cause increase of the energy in the molecule 
leading to decomposition. Sensitization with acetone and benzophenone lead to very 
slow reactions and decomposition of starting material. 
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Table 1: Optimization of reaction conditions for the intramolecular [2+2]-PCA. 
  ֤
# 
s.m. PG 
λ 
[nm] 
Solvent Additives 
[c] 
[mM] 
Reaction 
time 
P 
Yield  [%] 
1 
20b Boc 254 MeCN none 5 1 h 
21b 
75 
2 
20a Cbz 254 MeCN none 5 1 h 
21a 
57 
3 
20a Cbz 300 acetone none 5 5 days 
21a 
decomposition 
4 
20a Cbz 350 MeCN 
0.1 equiv. 
Ph2CO 
5 5 days 
21a 
decomposition 
 
The synthesis of complex photoproducts 21a and 21b was reported. 
Optimization of the intramolecular [2+2]-PCA reaction was accomplished. The unique 
1,3-dioxin-4-ones derivatives can be used as molecular scaffolds given the variety of 
opportunities of further functionalization. The dioxinone ring can be cleaved in basic 
conditions providing two new exit vectors with a defined regiostereochemistry. These 
novel and easy accessed scaffolds have a vast potential in the synthesis of complex 
natural products. 
2.2-1,3-Oxathiin-6-ones 
Coumarins with an exocyclic sulfur have been used by Carreira et al. in [2+2] 
PCA. Active allenylsilane 22 undergoes intramolecular [2+2]-PCA with enone to form 
cyclobutane adduct 23 which can further undergoes a protodesilylation .This was a 
step forward to the use of sulfur in intramolecular [2+2]-PCA (Scheme 9).13 
22
23
hν (λ293 nm)
hexane
80%
 
Scheme 9 
Cyclobutane rings with a sulfur atom attached are compounds exhibiting 
interesting properties. Although [2+2]-PCA reactions have been proven to be a useful 
synthetic tool to form the cyclobutane moiety, there is not much precedence about 
the use of this photochemical step in the formation of cyclobutane ring substituted 
with sulfur atoms. 
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Margaretha et al.14 have reported several experiments regarding 
intermolecular photocycloaddition of 2,2-dimethyl-3H-thiopyran-4-one (Scheme 10). 
Irradiation of 2,2-dimethyl-3H-thiopyran-4-one at a wavelength of 350 nm in benzene 
in the presence of substituted alkenes afforded several different photoadducts with 
specific stereochemistry. While with 2-chloroacrylonitrile there was only formation of 
[2+2]-photocycloadducts, in the presence of isoprene [2+4]-photocycloadducts were 
also isolated. This research group has described that the regio- and stereospecificity 
as well as the type of adducts formed strongly depended on the chosen alkene to 
react with the thiopyranone. 
24
25a
25b
26a 26b
27
28a
28b
29a 29b
hν 
hν hν 
hν 
hν 
hν 
Scheme 10 
The sulfur derived 1,3-oxathiine-6-ones are known,Erro! Marcador não 
definido. however they have not been employed in [2+2]-PCA.  
In the 1970’s the condensation of thiobenzophenone with acetylenes was 
reported with good yields.15 Years later the same approach was used by Okuma et 
al.Erro! Marcador não definido. to condense thioketones with propiolic acids. The 
successful treatment of adamantane-2-thione with propiolic acid in refluxing toluene 
to form the correspondent spiro derivative with high yields served as inspiration for 
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the synthesis of a new and unique photoprecursor with a spiro adamantane residue 
connected to a 1,3-oxathiin-6-one (Scheme 11). 
30 3231
PhMe
reflux
R=H,Me, Ph  
Scheme 11 
The desired propiolic acid was synthesized from commercially available 
propargylamine by protection with CbzCl to furnish the protected amine 33. Alkylation 
with allyl bromine using NaH as base gave benzyl allyl(prop-2-yn-1-yl)carbamate 34; 
further deprotonation of the terminal alkyne with n-BuLi followed by the carboxylation 
with CO2 gas originated the novel propiolic acid 35 (Scheme 12). 
NaH
allyl bromide
THF/DMF
0°c to rt, 1 h
96%
1) n-BuLi, -78 °C, 15 min
2) CO2 (gas), -50 °C, 15 min
THF
73%
33 34 35  
Scheme 12 
The propiolic acid 35 was condensed with the known adamantane-2-thione.15 
The photoprecursor 36 was obtained by simply refluxing in toluene for 18 h in 75% 
yield (Scheme 13). In contrast to the large excess of propiolic acid (3 equiv.) 
described by Okuma et al., equimolar amounts of propiolic acid and adamantane-2-
thione were sufficient to obtain 36 in 75% yield. 
30
toluene
reflux, 18 h
75%
36
(298 = 5474 M
-1.cm-1)
35
 
Scheme 13 
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The UV spectrum of compound 36 exhibited a strong absorption at 298 nm 
what predicted that direct irradiation of the photoprecursor at 300 nm would result 
most likely in quick photodecomposition. Considering the UV spectrum of 20a, the 
sulfur derivative 36 showed a strong bathochromic shift (~50 nm) (Figure 1).  
 
Figure 1: UV-spectrum of compounds 20a and 36 measured in 50 μM in acetonitrile. The 
green dashed box represents the ideal wavelength of irradiation to perform a photoreaction 
A first attempt to synthesize compound 37 was done by simple irradiation at 
350 nm at room temperature using diethyl ether as a solvent (5 mM for 18 h). 
Although there was a significant consumption of starting material 36, full conversion 
was not achieved and no product could be isolated. As expected increasing the 
energy by irradiation at 300 nm using diethyl ether as solvent (5 mM) resulted in full 
photodecomposition in less than 30 min. 
While the direct irradiation at 350 nm did not result in desired product 
formation, irradiation at 300 nm was too high in energy leading to a quick 
decomposition of the starting material. Therefore the possibility of triplet sensitization 
was considered. A first test reaction was performed by irradiating the substrate at 350 
nm in acetonitrile (5 mM) in the presence of 0.1 equiv. of benzophenone at room 
temperature. After 10 hours there was full consumption of starting material and the 
product 36 was isolated in 65% yield (Scheme 14).  
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0.1eq Ph2CO
MeCN (5 mM)
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37  
Scheme 14 
Another test reaction was performed to assess the efficacy of acetone as a 
solvent but also as triplet sensitizer. After 10 hours of irradiation at 350 nm at room 
temperature there was complete consumption of starting material but the isolated 
yield was just 35%. These results showed that triplet sensitization using 0.1 eq. of 
benzophenone in acetonitrile were the better conditions to perform this particular 
[2+2]-PCA (Table 2). 
Table 2: Optimization of reaction conditions for the intramolecular [2+2]-PCA. 
# 
s. m. PG 
λ 
[nm] 
Solvent Additives 
[c] 
[mM] 
Reaction 
time 
Yield of 37 [%] 
1 36 Cbz 300 Et2O none 9 12 h decomposition 
2 36 Cbz 350 Et2O none 9 0.5 h decomposition 
3 36 Cbz 350 acetone none 5 10 h 35 
4 
36 Cbz 350 MeCN 
0.1 eq. 
Ph2CO 
5 10 h 65 
 
The complex product 37 was successfully synthetized from a novel propiolic 
acid (35) and the known thioadamatanone followed by a [2+2]-PCA. Using reliable 
and known procedures the innovative photoproduct 37 has proven, once again,  that 
sulfur and photochemistry are not incompatible. 
Once again a complex novel tricyclic moiety was accessed. To our knowledge 
this is the first example where a cis-relationship of a carboxyl group and a low valent 
sulfur has been accessed by [2+2]-PCA. The optimization of the reaction conditions 
showed that in this case triplet sensitization is the key to the success of using low 
valent sulfur in photocycloadditions.  
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2.3-Conclusion  
The synthesis of exciting novel photoproducts has been reported. For the first 
time an approach towards the functionalization of the easy accessible 6-
(bromomethyl)-2,2-dimethyl-4H-1,3-dioxin-4-one (17) with nitrogen nucleophiles was 
described. A novel heterocyclic moiety fused with the dioxin-4-one ring was achieved 
by a common procedure of [2+2]-PCA reaction. A variety of exciting new complex 
tricyclic skeletons were synthetized. Studies of optimization of the synthesis proved 
that Boc was the preferred protecting group and that photosensitization had no 
beneficial impact in the synthesis of the photoproduct. 
Significant differences between the UV absorption of the 1,3-dioxin-4-ones 
and its sulfur analogs (1,3-oxathiin-6-ones) were verified. A strong bathochromic shift 
(~50 nm) was observed in the UV-spectrum of the sulfur compound in comparison to 
the 1,3-dioxin-4-one. The light absorption characteristics of the compounds have 
consequences in the choice of the reactions conditions, such as the wavelength of 
irradiation and presence or absence of sensitizers. Sensitization in the 
photocycloaddition of the sulfur derivatives was key to success  
Despite the limited number of literature examples in this area, a [2+2]-PCA 
was performed successfully with a sulphur derivative. 1,3-Oxathiin-6-one derivatives 
can be used as substrates in [2+2]-PCA to access novel scaffolds with potential 
interest in medicinal chemistry. The regio- and diasteroselective cis conformation of 
the fused 1,3-oxathiin-6-one cyclobutane ring, with sulfur substituents, is completely 
groundbreaking in this field.  
The condensation of adamantane-2-thione with propiolic acids has proven to 
be efficient in the synthesis of 1,3-oxathiin-6-ones derivatives.  
 In summary, the set of reactions described provide a convenient access to 
various derivatives of 1,3-dioxin-4-ones and 1,3-oxathiin-6-ones that were employed 
successfully in [2+2]-PCA reactions. Completely novel complex photoproducts have 
shown versatility as molecular scaffolds allowing a great number of opportunities for 
further decoration. 
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2.4-Experimental section: 
 
General: For the photoreactions a Rayonet RPR 200 merry-go-round reactor, 
equipped with 16 Rayonet RPR-2537 Å lamps (λ= 254, 300 and 350 nm) was used. 
Unless otherwise stated, the reactions were stopped when the starting material was 
fully consumed according to thin layer chromatography (TLC) and/or LC/MS analysis. 
Compounds were detected by UV (λ=254 nm), CAM (cerium ammonium molybdate 
solution) or KMnO4. 
1H NMR: Bruker AV-300, AV-400 and AV-600 recorded at 300 K 
unless otherwise indicated. Chemical shifts are reported relative to the solvent 
[CHCl3: δ (
1H) =7.26 ppm, DMSO δ (1H) =2.50 ppm as reference. The relative 
configuration of the products was determined by two-dimensional NMR spectra 
(COSY, NOESY, HSQC, HMBC). The UV-spectrum and extension coefficient (ε) 
were conducted on a UV-Vis Thermo Evolution 220 spectrophotometer. HRMS data 
were recorded by electron spray ionization (ESI) on an ion trap mass spectrometer. 
 
6-(Bromomethyl)-2,2-dimethyl-4H-1,3-dioxin-4-one (17): 
A mixture of 2,2,6-trimethyl-4H-1,3-dioxin-4-one (2.97 g, 20.9 
mmol, equiv: 1), N-bromosuccinimide (4.09 g, 23 mmol, equiv: 1.1) and 
AIBN (105 mg, 637 µmol, Eq: 0.0305) in dichloromethane (105 mL) 
was irradiated with a 300 W sunlamp (Osram Ultra-Vitalux). The 
mixture refluxed for 2,5 h. All volatiles were removed under vacuum and the crude 
material was purified by flash chromatography (silica gel, 100 g, 0% to 5% EtOAc in 
heptane) to give the 6-(bromomethyl)-2,2-dimethyl-4H-1,3-dioxin-4-one (3.95 g, 58% 
yield) as a light yellow liquid. 
According to literature:11 
1H NMR (600 MHz, CDCl3) δ ppm 1.72 (s, 6H), 3.88 (s, 2H), 5.53 (s, 1H).  
6-((Allylamino)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one (19):  
6-(Bromomethyl)-2,2-dimethyl-4H-1,3-dioxin-4-one (500 mg, 
2.26 mmol, equiv: 1.0) was dissolved in THF and cooled to 0 °C. A 
solution of prop-2-en-1-amine (129 mg, 170 µl, 2.26 mmol, equiv: 1.0) 
and NEt3 (252 mg, 347 µl, 2.49 mmol, equiv: 1.1) in THF was added, 
and the reaction mixture was stirred at 23 °C during 18 h. All volatiles 
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were removed under vacuum. The crude material was purified by flash 
chromatography (silica gel, 20 g, 0% to 100% EtOAc in heptane) to give 6-
((allylamino)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one (446 mg, 40% yield) as a 
colorless oil. 
1H NMR (600 MHz, CDCl3) δ ppm 1.70 (s, 6 H) 3.27 (dt, J=6.0, 1.4 Hz, 2 H) 3.36 (d, 
J=0.9 Hz, 2 H) 5.11 - 5.25 (m, 2 H) 5.47 (s, 1 H) 5.80 - 5.91 (m, 1 H) 
HRMS m/z=198.1124 [M+H]+ calculated from C10H15NO3 (M=197.10519) 
Benzyl allyl((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)carbamate (20a): 
To a mixture of 6-((allylamino)methyl)-2,2-dimethyl-4H-1,3-
dioxin-4-one (82 mg, 416 µmol, equiv: 1.0) and sodium bicarbonate 
(559 mg, 6.65 mmol, equiv: 16) in dichloromethane (245 µl) at 23 °C. 
Cbz-Cl (213 mg, 178 µl, 1.25 mmol, equiv: 3) was added dropwise. 
The mixture was stirred at 23°C during 16 h, poured into H2O and 
extracted with dichloromethane. The organic layers were collected and dried over 
Na2SO4. All volatiles were removed under vacuum. The crude material was purified 
by flash chromatography (silica gel, 10 g, 0% to 100 %, EtOAc in heptane) to give 
benzyl allyl((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)carbamate (110 mg, 80% 
yield) as a colorless oil. 
1H NMR (600MHz, CDCl3) δ ppm 1.52 (s, 3 H) 1.68 (s, 3 H) 3.86 (s, 4 H) 3.92 (br d, 2 
H) 5.13 - 5.20 (m, 2 H) 5.32 (s, 1 H) 5.70 - 5.83 (m, 1 H) 
LCMS (ESI) m/z=314.9 [M+NH4]
+ calculated from C15H23NO5 (M=297) 
tert-Butyl allyl((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)carbamate (20b): 
6-((Allylamino)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one (180 
mg, 913 µmol, equiv: 1.0) was dissolved in THF (2.28 mL), and Boc2O 
(219 mg, 233 µl, 1.00 mmol, equiv: 1.1) was added. The reaction 
mixture was heated at 40 °C during 2 hours. All volatiles were 
removed under vacuum. The crude material was purified by flash 
chromatography (silica gel, 10 g, 0% to 100 % EtOAc in heptane) to give tert-butyl 
allyl((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)carbamate (113 mg, 42% yield) as 
an orange oil.  
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1H NMR (600 MHz, CDCl3) δ ppm 1.28 - 1.79 (m, 7 H) 3.74 - 4.14 (m, 4 H) 5.06 -5.25 
(m, 4 H) 5.26 - 5.41 (m, 1 H) 5.57 - 5.96 (m, 1 H) 7.29 - 7.48 (m, 5 H) 
HRMS m/z= 332.14875 [M+H]+ calculated from C18H21NO5 (M=331.1418) 
(4aRS,5aSR,8aSR)-Benzyl 2,2-dimethyl-4-oxotetrahydro-4H-
[1,3]dioxino[4',5':1,4]cyclobuta[1,2-c]pyrrole-7(8H)-carboxylate (21b): 
In a 100 ml Kjeldahl quartz vessel a solution of benzyl 
allyl((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)carbamate (905 
mg, 2.73 mmol, equiv: 1.0) in acetonitrile (546 mL) was degassed 
bubbling argon through the solution, under sonication, for 30 min. 
Then the mixture was irradiated in a Rayonet RPR-200 reactor (16 x 
8 W lamps) at 254 nm for 1 h. LC/MS indicated total consumption of starting material. 
All volatiles were removed under vacuum. The crude material was purified by flash 
chromatography (silica gel, 20 g, 0% to 100% EtOAc in heptane) to give 
(4aRS,5aSR,8aSR)-benzyl 2,2-dimethyl-4-oxotetrahydro-4H-
[1,3]dioxino[4',5':1,4]cyclobuta[1,2-c]pyrrole-7(8H)-carboxylate (547 mg, 60% yield) 
as a colorless oil.  
1H NMR (600 MHz, CDCl3) δ ppm 1.52 (s, 3 H) 1.59 (s, 3 H) 2.05 (br s, 1 H) 2.54 – 
2.59 (m, 1 H) 2.82 - 2.86 (m, 1 H) 3.08 (br s, 1 H) 3.38 – 3.46 (m, 3 H) 4.08  7.33 – 
7.41 (m, 5 H) 
LC/MS (ESI) m/z= 230.6 [M-Boc]- calculated from C18H21NO5 (M=331.1419) 
(4aRS,5aSR,8aSR)-tert-Butyl 2,2-dimethyl-4-oxotetrahydro-4H-
[1,3]dioxino[4',5':1,4]cyclobuta[1,2-c]pyrrole-7(8H)-carboxylate (21a): 
tert-Butyl allyl((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl) 
carbamate (20 mg, 67.3 µmol, equiv: 1.0) was dissolved in acetonitrile 
(13.5 mL) and irradiated at 254 nm during 1 hour. LC/MS indicated 
total consumption of starting material. All volatiles were removed 
under vacuum. The crude material was purified by flash 
chromatography (silica gel, 20 g, 0% to 100% EtOAc in heptane) to give 
(4aRS,5aSR,8aSR)-tert-Butyl 2,2-dimethyl-4-oxotetrahydro-4H-[1,3] dioxino[4',5':1,4] 
cyclobuta[1,2-c]pyrrole-7(8H)-carboxylate (15 mg, 75% yield) as a colorless oil. 
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1H NMR (600 MHz, CDCl3) δ ppm 1.49 (s, 9 H) 1.53 (s, 6 H) 2.05 (br s, 1 H) 2.56 
(ddd, J= 13, 9.9, 4.7 Hz, 1 H) 2.82 (br dd, J= 13, 9.9 Hz, 1 H) 3.15 (br dd, J= 13, 9.9 
Hz, 1 H) 3.31 – 3.38 (m, 4 H) 
GC/MS (EI): m/z=198 [M-Boc]+ calculated from C15H13NO5 (M=297.1576) 
Benzyl prop-2-yn-1-ylcarbamate (33): 
A vigorously stirred mixture of prop-2-yn-1-amine (12.85 g, 233 
mmol, equiv: 1.0) combined with a saturated solution of sodium 
bicarbonate (19.6 g, 300 ml, 233 mmol, equiv: 1.0) in dichloromethane (200 
mL) was cooled down to - 10 °C. Cbz-Cl (41.8 g, 35 mL, 245 mmol, equiv: 
1.05) was added via syringe within 2 min. The mixture was stirred at 23 °C during 18 
h. The reaction mixture was extracted with dichlorometane washed with water and 
brine. The organic layers were collected and dried over Na2SO4. All volatiles were 
removed under vacuum. The crude material was purified by flash chromatography 
(silica gel, 200 g, 0% to 25% EtOAc in heptane) to give benzyl prop-2-yn-1-
ylcarbamate (34.7 g, 78.6 % yield) as a light yellow oil. 
According to literature:16 
1H NMR (400MHz, CDCl3, 60 °C) δ ppm 7.36-7.29 (m, 5H), 5.14 (s, 2H), 4.85 (s, 1H), 
3.99 (dd, J = 5.7, 2.6 Hz, 2H), 2.23 (t, J = 2.6 Hz, 1H);  
HRMS: m/z =189.0790 [M+] calculated from C11H11NO2 (M=189.0786) 
Benzyl allyl(prop-2-yn-1-yl)carbamate (34):  
To a solution of benzyl prop-2-yn-1-ylcarbamate (1.08 g, 4.71 mmol, 
equiv: 1.0) and allyl bromide (767 mg, 549 µl, 6.34 mmol, equiv: 1.2) in a 
mixture of tetrahydrofuran (15 mL) and N,N-dimethylformamide (15 mL) ato 
0 °C. NaH (254 mg, 6.34 mmol, equiv: 1.2) was added carefully. This 
mixture was stirred at 23 °C during 1 h the reaction was carefully quenched with H2O. 
The product was extracted with EtOAc The organic layers were collected and dried 
over Na2SO4. All volatiles were removed under vacuum. The crude material was 
purified by flash chromatography (silica gel, 20 g, 0% to 30 % EtOAC in heptane) to 
give benzyl allyl(prop-2-yn-1-yl)carbamate (1.08 g, 89% yield) as a colorless oil. 
According to literature:16 
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1H NMR (400MHz, CDCl3, 60 °C) δ ppm 7.38-7.28 (m, 5H), 5.81 (ddt, J = 16.7, 10.7, 
5.9 Hz, 1H), 5.23-5.17 (m, 2H), 5.18 (s, 2H), 4.11 (br. d, J = 1.4 Hz, 2H), 4.04 (br. dt, 
J = 5.9, 1.3 Hz, 2H), 2.20 (t, J = 2.5 Hz, 1H) 
HRMS: m/z = 252.0994 [M+ Na]+ calculated from C14H15NO2 (M=252.0995). 
4-(Allyl((benzyloxy)carbonyl)amino)but-2-ynoic acid (35): 
To a stirred solution of benzyl allyl(prop-2-yn-1-yl)carbamate (7.32 
g, 31.9 mmol, equiv: 1.0) in tetrahydrofuran (22 ml) at -78 °C, n-
butyllithium (20 ml, 31.9 mmol, equiv: 1.0) was added and the solution 
became slight yellow. The reaction mixture was stirred for 15 min at -78 
°C. An excess of CO2 gas (14.1 g, 319 mmol, equiv: 10) was bubbled 
into the reaction during 15 minutes. When the CO2 gas was added the temperature 
raised until 50 °C. Consumption of starting material verified by LC/MS. Poured onto 
HCl 1 M and NaCl solid was added. The mixture was extracted with EtOAc. The 
organic layers were collected and dried over Na2SO4. All volatiles were removed 
under vacuum. The crude material was purified by flash chromatography (silica gel, 
100 g, 0% to 100% EtOAc in heptane) to give the 4-
(allyl((benzyloxy)carbonyl)amino)but-2-ynoic acid (6.4 g, 73% yield) as a brown oil. 
 (1R,3R,5R,7R)-Adamantane-2-thione17(30): 
(1R,3R,5R,7R)-Adamantan-2-one (19.44 g, 129 mmol, equiv: 
1.0) in pyridine (120 mL) was heated to 90°C, and phosphorus 
pentasulfide (7.02 g, 31.6 mmol, equiv: 0.244) was added. The reaction 
mixture was stirred at 90°C for 2h, and heating was turned off. The reaction mixture 
was cooled slowly until 23 °C and stirred during 18 h. A gum phase and a solution 
phase were formed. The pyridine solution phase was decanted and concentrated to 
dryness. The residual semi-solid was treated with heptane to give an orange solution 
containing a light-brown suspension. The suspension was removed by filtration. The 
filtrate was concentrated to dryness to give an orange solid. After the solid was 
dissolved in dichloroethane and purified by flash chromatography (silica gel, 100 g, 
100% heptane) to give (1R,3R,5R,7R)-adamantane-2-thione (18 g, 84% yield) as an 
orange solid. 
According to literature:Erro! Marcador não definido. 
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1H NMR (CDCl3) δ ppm 1.9-2.1 (m, 12 H), 3.43 (s, 2 H). 
Benzyl.allyl(((1R,3R,5R,7R)-6'-oxo-6'H-spiro[adamantane-2,2'-[1,3]oxathiin]-4'-
yl)methyl)carbamate (36): 
4-(Allyl((benzyloxy)carbonyl)amino)but-2-ynoic acid (6.41 
g, 23.5 mmol, equiv: 1.0) was added in one portion to a solution 
of (1R,3R,5R,7R)-adamantane-2-thione (1.3 g, 7.82 mmol, equiv: 
1.0) in toluene (58.8 mL). After the mixture had been heated at 
reflux for 18 h, all volatiles were removed under vacuum to give 
an orange oil. The crude material was purified by flash chromatography (silica gel, 
100 g, 0% to 100% EtOAc in heptane) to give the benzyl allyl(((1R,3R,5R,7R)-6'-oxo-
6'H-spiro[adamantane-2,2'-[1,3]oxathiin]-4'-yl)methyl)carbamate (2.57 g, 75 % yield) 
as an orange oil. 
1H NMR (600 MHz, DMSO, 120 °C) δ ppm 1.59-1.89 (m, 9 H) 1.95 (d, J=13.3 Hz, 2 
H) 2.19 (d, j=10.9 Hz, 2 H) 2.39 (s, 2 H) 3.92 (dt, J=5.8, 1.4 Hz, 2 H) 4.22 (d, j=1.2 
Hz, 2 H),5.04-5.26 (m, 5 H) 5.83 (ddt, J=17.2, 10.2, 5.9, 5.9 Hz, 1 H) 6.06 (t, J=1.3 
Hz, 1H) 7.17-7.49 (m, 6 H). 
HRMS m/z=440.1899 [M+H]+ calculated from C25H29NO4S (M=439.1827) 
(1'SR,3'SR,4aSR,5aSR,5'SR,7'SR,8aSR)-Benzyl4-oxotetrahydro-4H-
spiro[[1,3]oxathiino[4',5':1,4]cyclobuta[1,2-c]pyrrole-2,2'-adamantane]-7(8H)-
carboxylate (37): 
In a 100 ml Kjeldahl quartz vessel a solution of benzyl 
allyl(((1R,3R,5R,7R)-6'-oxo-6'H- spiro[adamantane-2,2'-
[1,3]oxathiin]-4'-yl)methyl)carbamate (100 mg, 227 µmol, equiv: 
1.0) and benzophenone (4.15 mg, 22.7 µmol, equiv: 0.1) in 
acetonitrile (45.5 mL) was degassed bubbling argon through the 
solution under sonication for 30 min. Then the mixture was irradiated in a Rayonet 
RPR-200 reactor (16 x 8 W lamps) at 350 nm for 10 h. All the volatiles were removed 
under vaccum. The crude material was purified by flash chromatography (silica gel, 
20 g, 0% to 100% EtOAc in heptane) to give 
(1'SR,3'SR,4aSR,5aSR,5'SR,7'SR,8aSR)-benzyl-4-oxotetrahydro-4H-
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spiro[[1,3]oxathiino[4',5':1,4]cyclobuta[1,2-c]pyrrole-2,2'-adamantane]-7(8H)-
carboxylate (64 mg, 64% yield) as a colorless oil. 
1H NMR (600 MHz, CDCl3) δ ppm 1.60-2.14 (m, 11 H) 2.15-2.40 (m, 3 H) 2.47 (d, 
J=12.8 Hz, 1 H) 2.69-2.86 (m, 2 H) 3.05 (s, 1 H),3.27-3.45 (m, 2 H) 3.51-3.83 (m, 1 
H) 3.92-4.47 (m, 1 H) 5.18 (s, 2 H) 7.28-7.53 (m, 5 H). 
HRMS m/z=440.1892 [M+H]+ calculated from C25H29NO4S (M=439.1818) 
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3-[2+2]-Photocycloaddition in the synthesis of novel 
conformationally restricted bis-pyrrolidines 
3.1-α,β-unsaturated lactones. 
Photochemical reactions, in particular the [2+2]-photocycloaddition of α,β-
unsaturated lactones has been widely explored. In recent years access to novel 
bridged bis-pyrrolidines has been studied. The interest in these moieties is related to 
their versatility as scaffolds in medicinal chemistry and the [2+2]-photocycloaddition 
reaction (PCA) was described as the key approach (Scheme 1).1,2 The synthesis of 
bis-pyrrolidines bearing angular methyl groups and fluorine atoms was achieved with 
good yields. However the [2+2]-PCA to get angular aryl substituents in the lactone 
part was described with low yields and long reaction times. 
38 39
40
h.ν
(254 nm)
MeCN
r.t., 1-16 h
60-90%
R' = H, Me, F, Ph, CF
3
, Br
R' = H, Me, F, Ph
R = H, Me, F
R = H, Me, F
 
Scheme 1 
Fluorinated compounds have been playing a huge role in medicinal chemistry 
in recent years. In an attempt to synthesize interesting fluorinated building blocks for 
medicinal chemistry Fort et al.3 used the intramolecular [2+2]-photocycloaddition of 
enones. The influence of the electron-withdrawing character of fluorine atoms that 
are directly attached to the double bond was studied (Scheme 2).  
41 42
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In most cases irradiation at 254 nm at room temperature in diethyl ether 
allowed to obtain the product with yields around 70%. These experiments proved that 
the fluorine-substitution in a position adjacent to double bond is compatible with 
[2+2]-photocycloaddition. 
The same research group also recently described the use of [2+2]-
photocycloaddition in 4-substituted furanones to diastereoselectively form building 
blocks with potential application in medicinal chemistry.  
The experiments showed that Boc and Cbz both are good protecting groups 
for 4-(allylaminomethyl)-2(5H)-furanones in photocycloaddition reactions. The Cbz 
group can be more useful because there is a larger variety of cleavage procedures 
and is more efficient in the protection of bulkier substrates. In some cases of the 
[2+2]-PCA acetonitrile has shown to be superior as a solvent than diethyl ether 
improving the yields for particular substrates.  
 Fort et al.2 reported the synthesis of 7-phenyl-substituted 3-aza-9-
oxatricyclo[5.3.0.01,5]-decan-8-one from the alkylation of the bromide 48. The 
bromide 48 was obtained through a synthetic route that started with the conversion of 
methyl-2-bromo-2-phenylacetate 43 to the corresponding diethoxy phosphonoacetate 
44a by an Arbuzov reaction.4 Saponification to the acid 44b followed by the alkylation 
with 3-chloro-2-oxypropyl acetate 45 gave the 3-acetoxy-2-oxopropyl 2-
(diethoxyphosphoryl)-2-phenylacetate 46 with 81% yield. An intramolecular Horner-
Emmons-Wadsworth reaction using LiHMDS delivered the corresponding lactone 
47a which was deacetylated to the alcohol 47b. A bromodehydroxylation with PBr3 
allowed access to the desired bromide 48 (Scheme 3). 
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Alkylation of the bromide 48 with allylamine, followed by a protection of the 
intermediate 49 with Boc2O gave the substituted lactone 50, the substrate for the 
[2+2]-PCA reaction (Scheme 4).  
48 49 50 51
NEt
3
THF
Boc
2
O 
THF
hν (300 nm)
MeCN
23 °C,5 days
72%
 
Scheme 4 
The [2+2]-PCA reaction was performed in MeCN as solvent, irradiating 50 at 
300 nm for 5 days. Although a yield of 72% was achieved the reaction time was very 
long in order to obtain full conversion. Attempts to diminish the reaction time were 
described, but the increase of energy by lowering the wavelength of irradiation (254 
nm) caused formation of side products. Therefore research towards the optimization 
and differentiation of angular substituents was still to be performed. 
Fluorinated aromatic rings are quite frequently present in compounds useful in 
medicinal chemistry. Within the aim of producing new medicinal chemistry scaffolds 
and with the knowledge obtained with the synthesis of 7-phenyl-substituted 3-aza-9-
oxatricyclo[5.3.0.01,5]-decan-8-one an attempt to synthetize the corresponding 2-
fluoro-phenyl derivative was made. 
 The 2-fluoro-phenyl equivalent of the alkyl bromide 48 was required as a 
starting material. In order to achieve the synthesis of bromide 58, a similar synthetic 
approach as the previous done for the alkyl bromide 48 was initially employed. 
However the yield of the Arbuzov reaction was low due to the fast decomposition of 
the starting material 52 by decarboxylation (Scheme 5). 
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Scheme 5 
Due to the low yield in the first step of the route and considering that the 
planned synthetic route had a projected length of more than 15 steps, an alternative 
approach was planned. The commercially available 2-(2-fluorophenyl)acetic acid 55 
was condensed with acetone using iso-propylmagnesium chloride as a base to form 
2-(2-fluorphenyl)-3-methylbut-2-enoic acid 56, followed by a double Wohl-Ziegler 
bromination to give the dibromide 57 (Scheme 6).  
i) i-PrMgCl, THF, 40 °C, 1 h, 
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ii) H
2
SO
4
, DCM, 23 °C,45 min,
  83%
NBS, AIBN
DCM
40 °C, 2.5 h
94%56 57
55
 
Scheme 6 
Lactonization to give 58 occurred in the presence of 5 eq. of aqueous sodium 
bicarbonate in tetrahydrofuran at 23 °C. An increase of the temperature from 40 °C to 
60 °C in the Wohl-Ziegler bromination lead to the in situ lactonization of some of the 
dibromide material. However, the complete cyclization of the dibromide did not occur 
due to equilibrium establishment. The bromination at 40 °C, followed by the 
lactonization under mildly basic conditions has been established as the most 
beneficial approach, since the yields were higher and purification process easier 
(Scheme 7). 
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Scheme 7 
The bromide 58 was alkylated with allyl amine then subsequently protected, 
using Boc anhydride, to obtain the photosubstrate 60.  
Several studies regarding the [2+2]-PCA reaction (Scheme 8) conditions with 
the aim of establishing good yields with reduced reaction times were performed 
(Table 1). 
hν
60 61  
Scheme 8 
Table 1: Optimization of reaction conditions  
# s.m. λ [nm] Solvent c [mM] Additives 
Reaction 
time 
Yield of 61 
(%) 
1 60 300 Et2O 20 none 22 h No conversion 
2 60 300 MeCN 7 none 22 h 30% 
3 60 300 MeCN 20 none 22 h 53% 
4 60 300 MeCN 42 none 22 h 36% 
5 60 300 Acetone 75 none 4-16 h 60% 
6 60 300 MeCN 20 
0.1 eq. 
Ph2CO 
Ph2O 
4 days 30% 
Initially a set of conditions similar to the ones described in the literature for the 
phenyl compound were used. Irradiation at 300 nm in MeCN, at various 
concentrations provided the product (61) with modest yields and long reaction times. 
In collaboration with Chembiotek, the synthesis of the photoproduct 61 was optimized 
to achieve a better yield in the [2+2]-PCA. Using the concept of triplet sensitization, 
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the photoprecursor 60 was irradiated at 300 nm in acetone as solvent and triplet 
sensitizer resulting in an increase of yield from 30% to 60% and a reduction of the 
reaction time from 144 h (6 days) to a maximum of 16 h in larger scale reactions (~12 
g). A method of achieving high yields, as well as a major decrease of reaction time in 
the [2+2]-PCA to access conformationally restricted bis-pyrrolidines was described. 
The use of sensitization besides novel is a highly versatile method of increasing the 
success of these type of reactions. The sensitization approach has proven to be a 
tool that can determine the success of [2+2]-PCA.  
3.2- Novel Spiro Compact Module 
The synthesis of the dimethyl derivative 64 has already been described.2 The 
alkylation reaction of the bromo-furanone 62 was performed with low yields. The 
sensitivity of the lactone to strongly basic conditions and the low nucleophilicity of the 
desired amine limited the success of the reaction (Scheme 9). 
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Scheme 9 
To improve the previously published work by increasing the complexity of the 
scaffolds a new synthesis route to access a novel photoprecursor was developed. 
The synthesis of novel BACE1 inhibitors is one of the goals of this work. By 
functionalization of the cyclobutane in order to obtain heterocyclic spiro motifs, a 
deep penetration of the S2’ pocket was expected. The first approach was towards the 
functionalization with a piperidine scaffold.Hence the right amine building block had 
to be accessed in order to be used as nucleophile to alkylate the bromo-furanone 62 
in a similar approach to the previous work.  
From the commercially available tert-butyl 4-Boc-piperidone 65 a standard 
Horner–Wadsworth–Emmons reaction using triethyl phosphonoacetate and sodium 
hydride as base produced the α,β-unsaturated ethyl ester 66 in quantitative 
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yield.Erro! Marcador não definido. Reduction of the ester with diisobutylaluminum 
hydride5 allowed the access to the correspondent allylic alcohol 67 (Scheme 10). 
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Scheme 10 
By a Mitsunobu approach using phthalimide as a nitrogen nucleophile 
intermediate 68 was produced.6 Hydrazinolysis of 13 in refluxing ethanol gave the 
desired primary amine 69 (Scheme 11).7 
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Scheme 11 
In order to form the desired substrate for the [2+2]-PCA the amine 69 was 
used as the nucleophile in an alkylation reaction with the known bromo-furanone 62. 
The yield of the alkylation with the bromo-furanone 62 - although low - is higher in 
comparison to the alkylation reaction used in the synthesis of dimethyl 
photopercursor 63 (Scheme 12). In an attempt to optimize the yield of the alkylation 
reaction the conditions were altered, replacing triethylamine in THF with a biphasic 
system of aqueous potassium carbonate in dichloromethane8. Yet the yield using 
triethylamine as base was still higher (55% vs 32%). The di-alkylated product was 
also isolated from the reaction what lead to the conclusion that the occurrence 
double-alkylation was the cause for the moderate yields. A reductive amination 
between the allylic amine and the 4-formylfuran-2(5H)-one (synthetized from 
oxidation of the 4-hydroxymethylfuran-2(5H)-one9) was performed as an alternative 
route to obtain 70. However the reaction mixture was unclean, and there was still 
formation of a mixture of mono- and di-substituted, in a higher ratio of the di-
substituted product than in the alkylation procedures. 
48 
 
69 70
NEt
3
THF
23 °C, 14 h
55%
 
Scheme 12 
The free amine group was further protected with Cbz under Schotten-
Baumann conditions to form 71. Due to the fact that Cbz has proven to have a nice 
behavior in [2+2]-PCA reactions and because the nitrogen in the piperidine was 
protected with Boc, Cbz appeared to be the best option as a protecting group. The 
fact that both nitrogen atoms in the molecule are protected with orthogonal protecting 
groups allowed the possibility of selective cleavage which would allow further 
functionalization (Scheme 14). 
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Scheme 13 
The UV spectrum of 71 was measured and the extension coefficient for the 
maximum wavelength (200 nm) was determined (ε200=29106 M
-1.cm-1). From the 
previous knowledge of the relation between the maximum wavelength of absorption 
the ideal interval of wavelength of irradiation was established (Figure 1).The starting 
point was 254 nm due to the fact that UV lamps with higher energy were not 
available.  
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Figure 1: UV-spectrum of 71 measured at 50 μM in acetonitrile. The green dashed box 
represents the ideal wavelength of irradiation to perform a photoreaction 
Although, from the UV spectrum it seems that the molecule would not uptake 
any energy at 254 nm, the UV lamps have a spectral distribution of wavelength and 
therefore emit radiation in an interval of wavelengths. The 254 nm lamps also emit 
radiation at lower wavelengths that provided sufficient energy for the photochemical 
process to occur. 
The photoprecursor 71 was irradiated at 254 nm in MeCN for 3 h to give a new 
conformationally restricted pyrrolidine 72 with a spiro-piperidine moiety in 34% yield. 
Steric hindrance is most likely the cause of the moderate yield (Scheme 14).  
71 72
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Scheme 14 
The synthesis of the desired complex spiro-piperidine photoproduct 72 was 
successful. This novel building block has an enormous level of complexity, 
compromising a tricyclic skeleton with a spiro-piperidine functionalization, which 
possesses a large variety of exit vectors that can be selectively functionalized. The 
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key step in allowing the establishment of the intricate moiety in a regioselective 
manner was the [2+2]-PCA. 
3.3-Synthesis of versatile 3-(hydroxymethyl)-2H-furan-5-
ones derivatives bearing a leaving group in 4-position 
The success of the [2+2]-PCA of functionalized α,β-unsaturated lactones and 
the possibility of their use as molecular scaffolds served as inspiration towards the 
synthesis of multipurpose functionalized lactones for achieving a more modular 
approach. 
In recent years cross-coupling reactions have played an important role in 
synthetic organic chemistry. Bromides are extremely versatile in cross coupling 
reactions, therefore, a lactone with a bromide functionality at the 4-postion was 
proposed as a convenient scaffold. Furthermore, the installation of a hydroxymethyl 
group in the 3-position would allow differential functionalization. It was expected that 
the combined functionalization of the 3- and 4-positions would enable the formation 
of a highly versatile building block, which can access a broad range of products 
suitable for the subsequent intramolecular [2+2]-PCA reaction. 
From the knowledge acquired in the synthesis of the different 2-substituted 
lactones it was predicted that the lactone type 73 would be accessible through the 
intermediate of the type 74 (Scheme 15). 
4-bromo-3-(hydroxymethyl)-2H-furan-5-one
73 74  
Scheme 15 
In 2004, Brückner et al. described the stereoselective preparation of 
trisubstituted double bonds from the condensation of brominated phosphonoacetate 
esters with aldehydes. The preparation of the α-brominated α,β-unsaturated esters 
was optimized with the use of several bases and solvents. The use of NaH in THF at 
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0 °C provided the better yield and selectivity in the condensation of a mixture of 
mono-dibromophosphonates and anisaldehyde (Scheme 16).10 
75 76 77a
77b
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THF
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99%
90:10
 
Scheme 16 
In order to avoid selectivity problems condensation of the ethyl 2-bromo-2 
(diethoxyphosphoryl)acetate with the symmetric 2-oxopropane-1,3-diyl diacetate was 
planned. The ethyl 2-bromo-2-(diethoxyphosphoryl)acetate 80 was synthesized by 
the double dehydrobromination of commercially available triethyl phosphonoacetate 
followed by selective reductive elimination of one bromine with tin(II)chloride 
dihydrate (Scheme 17).11 
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Scheme 17 
The condensation of the bromo-phosphonate 80 with the diacetoxyacetone in 
the presence of sodium hydride gave the desired product with a very low yield after a 
tedious purification process (Scheme 18). 
80
81
NaH
THF
0°C-23°C, 18 h
7%
 
Scheme 18 
An attempt to do the previous reaction with i-PrMgCl as base instead of NaH 
was made (Scheme 19).  
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Scheme 19 
With the use of i-PrMgCl and the bromide 80 the elimination product 82 was 
formed in a 1:1 proportion with the bromide 81. The formation of the elimination 
product and the fact that a mixture of both the mono- and dibromo phosphonates 
were used by Brückner et al. lead to the rationalization of using the dibromide instead 
of the monobromide as starting material.  
Knochel et al. reported the use of functionalized magnesium carbenoids in the 
synthesis of unsaturated esters. A bromine-magnesium exchange that can further be 
quenched with several electrophiles provided the corresponding unsaturated 
esters.12 The dibromide 79 was reacted with i-PrMgCl resulting in the formation of the 
mono bromide 80 in situ; this was verified by quenching a sample with water and 
analyzing using LC/MS. The bromide-magnesium exchange is driven by the 
difference of pKa of starting material and product. Upon completed conversion of the 
dibromide 79 to corresponding monobromide 80, the reaction mixture was quenched 
with diacetoxyacetone (Scheme 20). 
79
81
"reagent"
solvent
0°C-23°C, 18 h
 
Scheme 20 
Although higher than the yield of the reaction with the mono-bromide 80, the 
yield of this reaction was still low. Furanone 73 was an interesting building block for 
further derivatization. With that in mind a low yield synthesis was not convenient 
because larger quantities of furanone 73 were necessary for further plans. Therefore 
an attempt to optimize this particular step was performed (Table 2). 
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Table 2: Optimization of the synthesis of 81. 
# s.m. Solvent Reagent scale 
Reaction 
time 
P Yield 
of 26 
(%) 
Side products 
1 80 THF i-PrMgCl 500 mg 18 h 81 20% 
82(elimination) 
(1:1) 
2 80 THF NaH 500 mg 18 h 81 7% none 
3 79 THF i-PrMgCl 1 g 18 h 81 24 % none 
4 79 THF NaH 200 mg 18 h 81 
No 
product 
Not identified 
5 79 THF i-PrMgCl·LiCl 1 g 18 h 81 32% none 
6 79 THF i-PrMgCl·LiCl 25 g 18 h 81 10 % none 
 
After 18 h the reaction with sodium hydride was not finished and there was no 
product formation. Then an attempt using iso-propylmagnesiumchloride lithium 
chloride complex was made, and there was an increase of the yield. However when 
the scale up was done the yield was much lower. The use of lithium salts as 
additives, in particular LiCl, has shown to increase the rate of the bromine-
magnesium exchange. LiCl has the ability to cleave polymeric aggregates of iso-
propylmagnesiumchloride and thus increasing the reactivity of the magnesiate 
species.13 
The lactonization reaction occurred in the presence of acetyl bromide in 
methanol and gave the lactone 73 with 68% yield (Scheme 21).  
81
73
AcBr
MeOH
50°C, 2 h
68%
 
Scheme 21 
After the synthesis of a small amount of the bromo-furanone 73 the protection 
of the hydroxy group was done. A bulky silyl ether such TBDPS was chosen due to 
an increase of lipophilicity that would turn the compound easier to handle. The silyl 
ethers are stable in most of the cross coupling procedures. The protection reaction 
was conducted using the classic procedure of TBDPSCl, imidazole in DMF. 
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Unfortunately a bromine-chlorine exchange happened. The exchange lead to a 
formation of a 1:1 ratio between the chloride and the bromide that had overlapping 
retention times which did not allow separation by flash chromatography. In order to 
solve this issue TBDPSOTf should be used instead of the silyl chloride (Scheme 22). 
83 8473
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Scheme 22 
The synthetic route to obtain the bromide 73 was low yielding, inefficient and 
difficult to reproduce on a larger scale. An alternative route had to be found. The 
main goal of the bromide 73 was to access an intermediate with versatility in cross-
coupling reactions. Although bromides are one of the most used functionalities in 
cross-coupling reactions, triflates have been widely used as well.14,15 The synthesis 
of the triflate equivalent was planned  
The commercially available 3-(hydroxymethyl)-2H-furan-5-one (85) was 
protected with TBDPS. The rapid vicinal dihydroxylation by catalytic ruthenium 
tetraoxide gave the diol 87 compound in a high yielding procedure.16 The triflate was 
installed by a double sulfonylation and concomitant elimination procedure using triflic 
anhydride and pyridine to give the desired furanone 88.17 
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With a high yielding three step synthesis, access to the triflate 88 was 
successfully achieved.  
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3.4-Conclusion  
The behavior displayed by molecules interacting and absorbing light greatly 
varies. Understanding this behavior was key in order to determine the success of 
[2+2]-PCA. The comprehension and utilization of triplet sensitization has the potential 
to transform the use of photochemistry in organic synthesis. 
 Several novel molecular scaffolds were successfully synthetized. Optimization 
of the intramolecular [2+2]-PCA reaction of the 2-fluoro-phenyl derivative 61 led to 
the establishment of conditions that allow fast, clean high yielding reactions at larger 
scale.  
 A novel complex spiro compound was successfully synthetized. The position 
of the piperidine ring in the cyclobutane is innovative and pioneering. The 
establishment of the success of this [2+2]-PCA is cutting-edge when it comes to 
validate photochemistry as a way of achieving complexity. In the future attempts to 
higher levels of substitution of the cyclobutane moiety can be studied, knowing that 
steric hindrance does not fully prevent the [2+2]-PCA. 
 Two new versatile furanone-type building blocks were accessed. The bromide 
73 however isolated, the yields of the synthetic route were moderate for its purpose 
as a building block. Despite the low yields the synthesis was optimized. The bromine-
magnesium exchange from the dibromide phosphonate 79 has proven to be the 
better mechanism. Sodium hydride failed to live up to the expectations.  
The replacement of the bromine with a triflate group was a good solution. The 
synthesis of the triflate-furanone 88 is short with high yields. The versatility of the 
triflate 88 is at the same level as the bromide 73. Several protocols of cross-coupling 
reactions are described with vinylic triflates. 
High level of complexity and innovation was reported. The synthesis and 
optimization of new [2+2]-PCA protocols has a massive contribution to the further 
work in this area. The level of the versatility of the reported photoproducts allows 
creative functionalization to give a huge variety of novel compounds.  
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3.5-Experimental section: 
General: Unless otherwise stated, the reactions were stopped when the starting 
material was fully consumed according to thin layer chromatography (TLC) and/or 
LC/MS analysis. Compounds were detected by UV (λ=254 nm), CAM (cerium 
ammonium molybdate solution) or KMnO4. 
1H and 13C NMR: Bruker AV-300, AV-400 
and AV-600 recorded at 300 K unless otherwise indicated. Chemical shifts are 
reported relative to the solvent [CHCl3: δ (
1H) =7.26 ppm, δ (13C) = 77.0 ppm, DMSO 
δ (1H) =2.50 ppm, δ (13C) = 39.5 ppm] as reference. The relative configuration of the 
products was determined by two-dimensional NMR spectra (COSY, NOESY, HSQC, 
HMBC). HRMS data were recorded by electron spray ionization (ESI) on an ion trap 
mass spectrometer. 
2-(2-Fluorophenyl)-3-methylbut-2-enoic acid (56):  
To a solution of isopropylmagnesium chloride 2M in THF 
(100 mL, 200 mmol, equiv: 2.0) in tetrahydrofuran (100 mL) at 23 
°C was added dropwise a solution of 2-(2-fluorophenyl)acetic acid 
(15.4 g, 100 mmol, equiv: 1.0) in tetrahydrofuran (200 mL). The 
reaction mixture was stirred, with an overhead stirrer for 1 h at 40 °C. The reaction 
mixture was cooled to 0 °C and acetone (8.71 g, 11 mL, 150 mmol, equiv: 1.5) was 
added dropwise, without the temperature to go higher than 20 °C. After the complete 
addition, the reaction mixture was stirred for 1 h at 40 °C. The reaction was cooled to 
0 °C and added 100 mL 14% H2SO4, extracted with TBME, dried over Na2SO4, 
filtered off and evaporated totally. The residue was dissolved in 100 mL 
dichloromethane and added under ice bath cooling H2SO4 conc. (50 g). Stirred at 23 
°C for 45 minutes, the reaction mixture was poured onto ice water and extracted with 
dichloromethane. The organic layers were collected and dried over Na2SO4. All 
volatiles were removed under vacuum. The crude material was dissolved in methanol 
(100 mL) and added charcoal (1.6 g) was added and stirred at 50 °C for 30 min, 
filtered off and evaporated totally. Added heptane (50 mL) and stirred at 50 °C for 1 
h, cooled to 23 °C and filtered off the solid, dried in high vacuum to give 2-(2-
Fluorophenyl)-3-methylbut-2-enoic acid (13.51 g, 70% yield) as a white solid. 
According to literature:18  
1H NMR (300 MHz, CDCl3) δ ppm 1.74 (s, 3 H) 2.52 (s, 3 H), 7.68-8.26 (m, 4 H) 
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4-Bromo-3-(bromomethyl)-2-(2-fluorophenyl)but-2-enoic acid (57): 
A mixture of 2-(2-fluorophenyl)-3-methylbut-2-enoic acid 
(10.84 g, 55.8 mmol, equiv: 1.0) with NBS (19.9 g, 112 mmol, 
equiv: 2.0) and AIBN (183 mg, 1.12 mmol, equiv: 0.02) in 
dichloromethane (283 mL) was stirred at reflux overnight. The 
mixture was cooled to 23 °C and evaporated totally. The crude 
material was purified by flash chromatography (silica gel, 20 g 0% to 40% EtOAc in 
heptane). The product factions were combined and totally evaporated to give: 4-
bromo-3-(bromomethyl)-2-(2-fluorophenyl)but-2-enoic acid (18.53 g, 94% yield) as a 
yellow solid. 3-(-2-fluorphenyl)-5-hydroxy-4-methylfuran-2(5H)-one was isolated as a 
minor side product resulting of a double-elimination. 
4-(Bromomethyl)-3-(2-fluorophenyl)furan-2(5H)-one (58): 
To NaHCO3 in water 1M (263 mL, 263 mmol, equiv: 5.0) and 
tetrahydrofuran (279 mL) was added a solution of 4-bromo-3-
(bromomethyl)-2-(2-fluorophenyl)but-2-enoic acid (18.53 g, 52.6 
mmol, equiv: 1.0) in tetrahydrofuran (92.9 mL), and the mixture was 
stirred for 1.5 h at 23 °C. The mixture was extracted with water and 
EtOAc. The organic layers were collected and dried over Na2SO4. All volatiles were 
removed under vacuum. The crude material was purified by flash chromatography 
(silica gel, 100 g, 0% to 30% of EtOAc in heptane) to give 4-(bromomethyl)-3-(2-
fluorophenyl)furan-2(5H)-one (8.5 g, 60% yield) as a colorless oil.  
1H NMR (600 MHz, CDCl3) δ ppm 4.25 (d, J=0.6 Hz, 2 H) 5.10 (s, 2 H) 7.18 (ddd, 
J=9.9, 8.5, 1.0 Hz, 1 H) 7.26 - 7.30 (m, 1 H) 7.41 - 7.49 (m, 2 H) 
GCMS (EI): m/z=269.969 [M•]+ calculated from C11H8BrFO2 (M=269.969) 
4-((Allylamino)methyl)-3-(2-fluorophenyl)furan-2(5H)-one (59): 
Dropwise addition of allylamine (2.15 g, 2.82 mL, 37.6 mmol, 
equiv: 1.2) and triethylamine (3.17 g, 4.37 mL, 31.4 mmol, equiv: 1.0) 
in tetrahydrofuran (100 ml) to an ice bath cooled solution of 4-
(bromomethyl)-3-(2-fluorophenyl)furan-2(5H)-one (8.5 g, 31.4 mmol, 
equiv: 1.0) in tetrahydrofuran (100 mL). The ice bath was removed 
allowing the reaction to warm up to 23 °C and stirred 2 hours. The solid was filtered 
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and the solution was evaporated totally. The crude material was purified by flash 
chromatography (silica gel, 100 g, 0% to 100% EtOAC in heptane) and gave 4-
((allylamino)methyl)-3-(2-fluorophenyl)furan-2(5H)-one (5.43 g, 70% yield) as a light 
brown oil. 
tert-Butyl allyl((4-(2-fluorophenyl)-5-oxo-2,5-dihydrofuran-3-
yl)methyl)carbamate (60): 
A mixture of 4-((allylamino)methyl)-3-(2-fluorophenyl)furan-
2(5H)-one (5.43 g, 22 mmol, equiv: 1.0) with Boc-anhydride (5.03 g, 
5.35 mL, 23.1 mmol, equiv: 1.05) in tetrahydrofuran (162 mL) was 
stirred for 72 h at 23 °C. The reaction mixture was concentrated and 
purified by flash chromatography (silica gel, 100 g, 0% to 50% 
EtOAc in heptane) to give: tert-butyl allyl((4-(2-fluorophenyl)-5-oxo-2,5-dihydrofuran-
3-yl)methyl)carbamate (7.63 g, 100% yield) as a light yellow oil. 
 (3aRS,4aRs,7aSR)-tert-Butyl 3a-(2-fluorophenyl)-3-
oxohexahydrofuro[3',4':1,4]cyclobuta[1,2-c]pyrrole-6(1H)-carboxylate (61): 
A solution of tert-butyl allyl((4-(2-fluorophenyl)-5-oxo-2,5-
dihydrofuran-3-yl)methyl)carbamate (5 g, 14.40 mmol) in acetone (200 
mL, 72 mM) was deoxygenated by bubbling argon through the solution 
under sonication for 1h and then irradiated in a Rayonet RPR-200 
reactor (16 x 8 W lamps) (λ=300 nm) for 9 h. The solvent was removed 
in vacuum, and the crude material was purified by flash 
chromatography (silica gel, 100g, 15% to 30% EtOAc in hexane) to give 
(3aRS,4aRS,7aSR)-3a-(2-fluoro-phenyl)-3-oxo-tetrahydro-2-oxa-6-aza-
cyclobuta[1,2:1,4]dicyclopentene-6-carboxylic acid tert-butyl ester (3.01g, 60%) as an 
off white solid.  
1H NMR (600 MHz, CDCl3) δ ppm 1.11 - 1.69 (m, 9 H) 2.53 (dd, J=12.9, 6.6 Hz, 1 H) 
2.78 (dd, J=12.8, 8.5 Hz, 1 H) 2.87 - 3.10 (m, 2 H) 3.17 - 3.38 (m, 1 H) 3.46 - 3.82 
(m, 2 H) 4.30 - 4.52 (m, 2 H) 7.09 (d, J=8.5 Hz, 1 H) 7.23 (d, J=1.0 Hz, 1 H) 7.28 (br. 
s., 1 H) 7.32 - 7.41 (m, 1 H) 
HRMS: m/z= 248.1003 [M+H]+ calculated from C14H14FNO2 (M=247.1003) 
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tert-Butyl 4-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate (66): 
To a solution of triethyl phosphonoacetate (70.75 g, 63.2 
mL, 316 mmol, equiv: 1.26) in tetrahydrofuran (500 mL) at 0-5 °C. 
sodium hydride (60% in mineral oil) (12.1 g, 304 mmol, Eq: 1.21) 
was added portionwise, and the mixture was stirred for 30 min. 
Then a solution of tert-butyl 4-oxopiperidine-1-carboxylate (50 g, 
251 mmol, equiv: 1.0) in tetrahydrofuran (500 mL) was added dropwise and the 
mixture was stirred at 23 °C for 4 h. After the completion of the reaction (verified by 
TLC), water (500 mL) was added, and the water layers were extracted with EtOAc. 
The organic layers were collected and dried over Na2SO4. All volatiles were removed 
under vacuum leaving a white solid. The crude material was triturated with n-pentane 
(200 mL) at 23 °C for 15 min, then at 0 °C for 1.5 h, the solid was filtered off, washed 
with cold n-pentane and dried in high vacuum to give the first crop of tert-butyl 4-(2-
ethoxy-2-oxoethylidene)piperidine-1-carboxylate (62.16 g, 231 mmol, 92 % yield) as 
a white solid. The mother liquor was evaporated to give 18 g of yellow oil, which was 
purified by flash chromatography (silica gel, 100 g, 0% to 15% EtOAc in heptane) to 
give a second crop of tert-butyl 4-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate 
(4.95 g, 18.4 mmol, 7.32 % yield) as a white solid. Overall the tert-butyl 4-(2-ethoxy-
2-oxoethylidene)piperidine-1-carboxylate (67.11 g, 99% yield) was obtained as white 
solid. 
According to literature:19 
1H NMR (600 MHz, CDCl3) δ ppm: 1.26 (t, J = 7.0 Hz, 3 H) 1.46 (s, tBu, 9 H) 2.1-2.4 
(m, 2 H) 2.8-3.1 (m, 2 H) 3.1-3.6 (m, 4 H) 4.12 (q, J = 7.0 Hz, 2 H) 5.68 (br s, 1 H) 
 
tert-Butyl 4-(2-hydroxyethylidene)piperidine-1-carboxylate (67): 
To a solution of tert-butyl 4-(2-ethoxy-2-
oxoethylidene)piperidine-1-carboxylate (3.5 g, 13 mmol, equiv: 1.0) in 
toluene (30 mL) at -78 °C was added diisobutylaluminum hydride 
(~1.7 M in toluene, 25%) (19.1 ml, 32.5 mmol, equiv: 2.5) keeping the 
internal temperature below -50 °C. Stirring was continued at -78 °C 
slowly warming up to 0 ° for 3 h. MeOH (2 mL) was added, followed by a saturated 
aqueous solution of Seignette's salt (30 mL), and the mixture was warmed up to 23 
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°C. Extraction with EtOAc. The organic layers were collected and dried over Na2SO4. 
All volatiles were removed under vacuum. The crude material was purified by flash 
chromatography (silica gel, 50 g, 0% to 60% EtOAc in heptane) to give the tert-butyl 
4-(2-hydroxyethylidene)piperidine-1-carboxylate (2.737 g, 93% yield) as a colorless 
oil.  
According to literarture:20 
1H NMR (400 MHz, CDCl3) δ ppm 5.49 (t, J = 7.0 Hz, 1 H) 4.17 (d, J = 7.0 Hz, 2 H) 
3.42 (m, 4H) 2.26 (t, J = 5.8 Hz, 2 H), 2.18 (t, J = 5.8 Hz, 2 H) 1.57 (br s, 1H) 1.47 (s, 
9 H) 
tert-Butyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethylidene)piperidine-1-carboxylate 
(68): 
tert-Butyl 4-(2-hydroxyethylidene)piperidine-1-carboxylate (1 
g, 4.4 mmol, equiv: 1.0) was dissolved in THF (8.8 mL). Then 
triphenylphosphine (1.15 g, 4.4 mmol, equiv: 1.0) and phtalimide 
(647 mg, 4.4 mmol, equiv: 1.0) were added, and the system was 
covered with aluminum foil. Dropwise addition of diisopropyl 
azodicarboxylate (890 mg, 855 µl, 4.4 mmol, equiv: 1.0). The mixture was stirred at 
23 °C during 5h. The reaction mixture was washed with sodium bicarbonate and 
brine, extracted with ethyl acetate. The organic layers were collected and dried over 
Na2SO4. All volatiles were removed under vacuum. The crude material was purified 
by flash chromatography (silica gel, 40 g, 0% to 50% EtOAc in heptane) to give tert-
butyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethylidene)piperidine-1-carboxylate (1.27 g, 81% 
yield) as a light yellow oil.  
1H NMR (600 MHz, CDCl3) δ ppm 1.46 (s, 9 H) 2.14 (br t, J=5.0 Hz, 2 H) 2.45 (t, 
J=5.6 Hz, 2 H) 3.27 - 3.63 (m, 4 H) 4.29 (d, J=7.4 Hz, 2 H) 5.36 (s, 1 H) 7.64 - 7.76 
(m, 2 H) 7.80 - 7.91 (m, 2 H) 
HRMS: m/z= 257.1287 [M-BOC]+ calculated from C20H24N2O4 (M=356.1736) 
tert-Butyl 4-(2-aminoethylidene)piperidine-1-carboxylate (69): 
To a solution of tert-butyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethylidene)piperidine-1-
carboxylate (1.27 g, 3.56 mmol, Eq: 1) in ethanol (23 mL) hydrazine hydrate was 
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added (535 mg, 519 µl, 10.7 mmol, equiv: 3.0) was added and 
mixture was refluxed for 1 h. After cooling down to 23 °C, the 
resulting precipitate (phthalide) was filtered off and washed with a 
small amount of ethanol. The residue was concentrated and 
extracted with dichloromethane. The organic layers were washed with brine and dried 
with Na2SO4. The solvents were removed to give tert-butyl 4-(2-
aminoethylidene)piperidine-1-carboxylate (808 mg, 100% yield) as a light yellow oil. 
1H NMR (600 MHz, CDCl3) δ ppm 1.47 (s, 10 H) 1.98 - 2.40 (m, 4 H) 3.30 (d, J=7.0 
Hz, 2 H) 3.35 - 3.50 (m, 4 H) 5.34 (t, J=7.0 Hz, 1 H) 
HRMS: m/z= 227.1759 [M+H]+ calculated from C12H22N2O2 (M=226.1681) 
tert-Butyl 4-(2-(((5-oxo-2,5-dihydrofuran-3-
yl)methyl)amino)ethylidene)piperidine-1-carboxylate (70): 
To a solution of tert-butyl 4-(2-aminoethylidene)piperidine-1-
carboxylate (808 mg, 3.57 mmol, equiv: 1.0) in tetrahydrofuran (17.9 
mL), was added triethylamine (434 mg, 597 µl, 4.28 mmol, equiv: 
1.2). At 0 °C 4-(bromomethyl)furan-2(5H)-one (632 mg, 3.57 mmol, 
equiv: 1.0) was added and were left at 23 °C overnight. The reaction 
mixture was filtered and the solvents evaporated. The crude material 
was purified by flash chromatography (silica gel 20g, 0% to 100% EtOAc in heptane) 
to give tert-butyl 4-(2-(((5-oxo-2,5-dihydrofuran-3-
yl)methyl)amino)ethylidene)piperidine-1-carboxylate (628 mg, 55% yield) as an 
orange oil. 
1H NMR (600 MHz, CDCl3) δ ppm 1.43 - 1.50 (m, 20 H) 2.10 - 2.35 (m, 9 H) 3.12 (d, 
J=7.0 Hz, 2 H) 3.28 (d, J=7.1 Hz, 2 H) 3.33 - 3.50 (m, 12 H) 3.60 - 3.66 (m, 2 H) 4.79 
(d, J=1.7 Hz, 3 H) 4.83 (d, J=1.8 Hz, 2 H) 5.21 - 5.27 (m, 1 H) 5.29 - 5.35 (m, 3 H) 
6.00 (quin, J=1.7 Hz, 1 H) 6.04 (t, J=1.6 Hz, 2 H) 
HRMS: m/z =223.1454 [M-Boc]+ calculated from C17H26N2O4 (M=322.1892) 
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tert-Butyl 4-(2-(((benzyloxy)carbonyl)((5-oxo-2,5-dihydrofuran-3-
yl)methyl)amino)ethylidene)piperidine-1-carboxylate (71): 
A mixture of tert-butyl 4-(2-(((5-oxo-2,5-dihydrofuran-3-
yl)methyl)amino)ethylidene)piperidine-1-carboxylate (628 mg, 1.95 
mmol, equiv: 1.0) and sodium bicarbonate (818 mg, 9.74 mmol, 
equiv: 5.0) in dichloromethane (1.15 mL) and water (1.15 mL) was 
stirred at 0 °C. Dropwise addition of CBZ-Cl (498 mg, 417 µl, 2.92 
mmol, equiv: 1.5), was followed by stirring at 23 °C during 18 h. 
The reaction mixture was extracted with water and EtOAc. The organic layers were 
collected and dried over Na2SO4. All volatiles were removed under vacuum. The 
crude material was purified by flash chromatography (silica gel, 20 g, 0% to 100% 
EtOAc in heptane) to give tert-butyl 4-(2-(((benzyloxy)carbonyl)((5-oxo-2,5-
dihydrofuran-3-yl)methyl)amino)ethylidene)piperidine-1-carboxylate (368 mg, 41% 
yield) as a colorless oil. 
1H NMR (400 MHz, DMSO, 120 °C) δ ppm 1.20 - 1.51 (m, 13 H) 1.97 - 2.23 (m, 6 H) 
3.13 - 3.41 (m, 6 H) 3.93 (d, J=7.1 Hz, 3 H) 4.11 - 4.32 (m, 3 H) 4.64 - 4.83 (m, 2 H) 
5.11 (s, 3 H) 5.22 - 5.34 (m, 1 H) 5.89 (t, J=1.8 Hz, 1 H) 7.01 - 7.56 (m, 5 H) 
LC/MS m/z= 357.1832 [M-Boc]+ calculated from C25H32N2O6 (M=456.2260) 
 6 
7 
(3aRS,4aRS,7aSR)-6-Benzyl 1'-tert-butyl 3-oxotetrahydro-1H-
spiro[furo[3',4':1,4]cyclobuta[1,2-c]pyrrole-4,4'-piperidine]-1',6(7H)-
dicarboxylate (72): 
In a quartz flask tert-butyl 4-(2-(((benzyloxy)carbonyl)((5-
oxo-2,5-dihydrofuran-3-yl)methyl)amino)ethylidene)piperidine-1-
carboxylate (100 mg, 219 µmol, equiv: 1.0) was dissolved in 
acetonitrile (45 mL) and bubbled argon through, under 
ultrasound for 20 min. This mixture was irradiated in a Rayonet 
RPR-200 reactor (16 x 8 W lamps) at λ=254 nm for 3 h. All the volatiles were 
removed under vacuum. The crude material was purified by flash chromatography 
(silica gel, 12 g, 0% to 100% EtOAc in heptane) to give (3aRS,4aRS,7aSR)-6-benzyl 
1'-tert-butyl 3-oxotetrahydro-1H-spiro[furo[3',4':1,4]cyclobuta[1,2-c]pyrrole-4,4'-
piperidine]-1',6(7H)-dicarboxylate (34 mg, 34% yield) as an orange oil. 
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1H NMR (400 MHz, DMSO 120 °C) δ ppm 1.44 (s, 13 H) 1.53 - 1.66 (m, 3 H) 2.59 (s, 
1 H) 2.79 (s, 1 H) 3.13 - 3.55 (m, 7 H) 3.85 (d, J=12.2 Hz, 1 H) 3.95 (d, J=12.4 Hz, 1 
H) 4.23 (d, J=9.7 Hz, 1 H) 4.49 (d, J=9.7 Hz, 1 H) 5.01 - 5.26 (m, 2 H) 7.39 (d, J=4.3 
Hz, 4 H) 
HRMS: m/z=357.1819 [M-Boc]+ calculated from C25H32N2O6 (M=456.2260) 
Ethyl 2,2-dibromo-2-(diethoxyphosphoryl)acetate (79): 
Ethyl 2-(diethoxyphosphoryl)acetate (45 g, 40 mL, 201 
mmol, equiv: 1.0) was dissolved in DME (400 mL). The reaction 
was colled down with a water bath and sodium hydride (60% in 
mineral oil) (14 g, 350 mmol, equiv: 1.74) was added carefully 
(exothermic reaction). The temperature was left to rise until 23 °C and stir for one 
hour. Cool down the reaction until 0 °C with an ice bath and add bromine (64.2 g, 
20.7 mL, 401 mmol, equiv: 2.0). The reaction stirred at 23 °C during 2 hours. Extract 
with water/EtOAc. All the volatiles were removed. The crude material was purified by 
flash chromatography (silica gel) first with 3:1 and then 1:1 Heptane: EtOAc to give 
ethyl 2,2-dibromo-2-(diethoxyphosphoryl)acetate (71.1 g, 93% yield) as a light yellow 
oil. 
According to literature:11 
1H NMR (600 MHz, CDCl3) δ ppm: 1.32 – 1.47 (m, 12 H) 4.28 – 4.46 (m, 8 H) 
31P NMR (300 MHz, CDCl3) δ ppm: 8.4 (s) 7.0 (s) 
 
Ethyl 2-bromo-2-(diethoxyphosphoryl)acetate (80) 
Ethyl 2,2-dibromo-2-(diethoxyphosphoryl)acetate (7.64 
g, 20 mmol, equiv: 1.0) was dissolved in ethanol (19.3 mL) in 
a ice bath. A solution of in water (38.5 mL) was added, 
maintaining the temperature lower than 10 °C. When the 
addition was complete, the reaction mixture was stirred for an additional 15 min at 23 
°C. The mixture was extracted with DCM and dried over Na2SO4. All the volatiles 
were removed. The crude material was purified by flash chromatography (silica gel, 
40 g, 0% to 100% EtOAc in heptane) to give ethyl 2-bromo-2-
(diethoxyphosphoryl)acetate (5.73 g, 95% yield) as a light yellow oil. 
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According to literature:11 
1H NMR (600 MHz, CDCl3) δ ppm: 1.32 (t, J= 7.1 Hz, 3 H) 1.38 (t, J= 7.1 Hz, 6 H) 
4.23 – 4.33 (m, 8 H) 
31P NMR (300 MHz, CDCl3) δ ppm 13.2 (m).  
 
2-(1-Bromo-2-ethoxy-2-oxoethylidene)propane-1,3-diyl diacetate (81): 
To a solution of ethyl 2,2-dibromo-2-
(diethoxyphosphoryl)acetate (2.41 g, 6.32 mmol, equiv: 
1.1) in THF (14.9 mL) at 0° C was added dropwise iso-
propylmagnesium chloride-lithium chloride complex (4.86 
mL, 6.32 mmol, equiv: 1.1), and the mixture was stirred at 
0° C for 30 minutes (conversion of the di-bromo to the mono-bromo compound 
checked by LC/MS). 2-Oxopropane-1,3-diyl diacetate (1 g, 5.74 mmol, equiv: 1.0) 
was added. The reaction was stirred at 23 °C during 18 h. There was no full 
conversion of starting material. The reaction mixture was poured into sat NH4Cl, 
extracted with TBME and the organic layer were dried over Na2SO4. All the volatiles 
were removed by vacuum. The crude material was purified by flash chromatography 
(silica gel, 20 g, 0% to 100% EtOAc in heptane).There was isolation of as light yellow 
oil. (588 mg, 32% yield). 
1H NMR (600 MHz, CDCl3) δ ppm 1.30 - 1.40 (m, 3 H) 2.04 - 2.12 (m, 6 H) 4.32 (q, 
J=7.1 Hz, 2 H) 4.91 (d, J=11.4 Hz, 4 H) 
 HRMS m/z= 325.0095 [M+H]+ calculated from C11H15BrO6 (M=322.0038) 
3-Bromo-4-(hydroxymethyl)furan-2(5H)-one (73): 
In a flask with a condenser 2-(1-bromo-2-ethoxy-2-
oxoethylidene)propane-1,3-diyl diacetate (4.75 g, 14.7 mmol, equiv: 1.0) 
was dissolved in methanol (45 mL). Add acetyl bromide (181 mg, 109 
µL, 1.47 mmol, equiv: 0.1) and stirred at 23 °C during 18 h. The TLC 
showed still starting material, so 10 mL of AcBr were added and the reaction mixture 
was warmed until 50 °C during 1,5 h. The reaction mixture was evaporated and 
azeotroped 3 times with toluene to give the 3-bromo-4-(hydroxymethyl)furan-2(5H)-
one (1.92 g, 9.95 mmol, 67.7 % yield) as a brown oil. The crude material was purified 
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by flash chromatography (silica gel, 40 g, 0% to 100% EtOAc in heptane) to give 3-
bromo-4-(hydroxymethyl)furan-2(5H)-one (1.92 g, 68% yield) as a yellow oil. 
1H NMR (600 MHz, CDCl3) δ ppm 2.26 (br s, 1 H) 4.69 (s, 2 H) 4.98 (t, J=1.1 Hz, 2 H) 
GCMS (EI): m/z =192.1 [M•]+ calculated from C5H5BrO3(M=192.995) 
4-(((tert-Butyldiphenylsilyl)oxy)methyl)furan-2(5H)-one (86): 
In a flask, 4-(hydroxymethyl)furan-2(5H)-one (5.041 g, 44.2 
mmol, equiv: 1.0) was combined with DMF (58.9 mL) to give a light 
brown solution. Imidazole (4.51 g, 66.3 mmol, equiv: 1.5) was added. 
TBDPS-Cl (14.6 g, 13.6 mL, 53 mmol, equiv: 1.2) was added 
dropwise. The reaction mixture was stirred at 23 °C during 18 h and 
extracted with TBME and water. The organic layer was dried with Na2SO4 and the 
solvents removed. The crude material was purified by flash chromatography (silica 
gel, 80 g, 0% to 50% EtOAc in heptane) to give 4-(((tert-
butyldiphenylsilyl)oxy)methyl)furan-2(5H)-one (12.25 g, 79% yield) as a white solid. 
1H NMR (600 MHz, CDCl3) δ ppm 1.08 (s, 9 H) 4.50 - 4.61 (m, 2 H) 4.74 - 4.82 (m, 2 
H) 6.03 (t, J=1.9 Hz, 1 H) 7.38 - 7.43 (m, 4 H) 7.45 - 7.49 (m, 2 H) 7.61 - 7.66 (m, 4 
H) 
HRMS m/z= 353.1564 [M+H]+ calculated from C12H24O3Si (M=352.1491) 
(3RS,4SR)-4-(((tert-Butyldiphenylsilyl)oxy)methyl)-3,4-dihydroxydihydrofuran-
2(3H)-one (87): 
To a vigorously stirred soltution of 4-(((tert-
butyldiphenylsilyl)oxy)methyl)furan-2(5H)-one (4.97 g, 14.1 mmol, 
equiv: 1.0) in ethyl acetate (89.5 mL)/acetonitrile (89.5 mL) at 0 °C 
was added a solution of ruthenium(III) chloride hydrate (223 mg, 987 
µmol, equiv: 0.07) and sodium periodate (4.52 g, 21.1 mmol, equiv: 
1.5) in water (24.9 mL). The two-phase mixture was stirred vigorously for 3 min and 
quenched with a saturated solution of Na2S2O3. The aqueous phase was extracted 
with EtOAc. The organic layers were collected and dried over Na2SO4. All volatiles 
were removed under vacuum. The crude material was purified by flash 
chromatography (silica gel, 20g, 0% to 50% EtOAc in heptane) to give (3RS,4SR)-4-
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(((tert-butyldiphenylsilyl)oxy)methyl)-3,4-dihydroxydihydrofuran-2(3H)-one (5.10 g, 
94% yield) as a light yellow foam. 
1H NMR (600 MHz, CDCl3) δ ppm 1.05 - 1.14 (m, 9 H) 2.77 (d, J=4.4 Hz, 1 H) 2.88 
(d, J=1.4 Hz, 1 H) 3.70 (s, 2 H) 4.23 (d, J=10.0 Hz, 1 H) 4.36 (dd, J=10.0, 1.3 Hz, 1 
H) 4.53 (d, J=4.2 Hz, 1 H) 7.39 - 7.45 (m, 4 H) 7.48 (d, J=7.3 Hz, 2 H) 7.60 - 7.67 (m, 
4 H) 
HRMS m/z= 385.1479 [M-H]- calculated from C21H26O5Si 386.1551  
4-(((tert-Butyldiphenylsilyl)oxy)methyl)-2-oxo-2,5-dihydrofuran-3-yl 
trifluoromethanesulfonate (88): 
To a solution of (3RS,4SR)-4-(((tert-butyldiphenylsilyl) 
oxy)methyl)-3,4-dihydroxydihydrofuran-2(3H)-one (2 g, 5.17 mmol, 
equiv: 1.0) in dichloromethane (49 mL) held at -78 °C under argon 
were successively added pyridine (2.05 g, 2.09 mL, 25.9 mmol, 
equiv: 5.0) and a solution of trifluoromethanesulfonic anhydride (4.38 
g, 2.62 mL, 15.5 mmol, equiv: 3.0) in dichloromethane (16.3 mL). After 15 min stirring 
at -78 °C, the reaction mixture was slowly warmed to -5 °C over a period of 3 h. The 
reaction was then poured into cold diethyl ether (40 mL). The precipitate was 
removed by filtration and the filtrated was evaporated in vacuum at 0 °C. The crude 
material was purified by flash chromatography (silica gel, 40 g, 0% to 50% EtOAc in 
heptane) to give 4-(((tert-butyldiphenylsilyl)oxy)methyl)-2-oxo-2,5-dihydrofuran-3-yl 
trifluoromethanesulfonate (2.13 g, 82% yield) a light yellow oil that further crystalized 
as white crystals . 
1H NMR (600 MHz, CDCl3) δ ppm 1.00 - 1.13 (m, 9 H) 4.69 (s, 2 H) 4.96 (s, 2 H) 7.38 
- 7.69 (m, 10 H) 
GCMS (EI): m/z= 518.2 [M+NH4]
+ calculated from C22H23F3O6SSi(M=500.560) 
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4-Further Functionalization of [2+2]-PCA products 
4.1-Compact Modules 
An approach to the synthesis of conformationally restricted bis-pyrrolidines 
has been described using as starting material the photoproduct 89. The lactone ring 
was opened with benzylamine in THF forming the corresponding benzylamide and a 
primary alcohol 90. Mesylation of the free hydroxyl group and subsequent treatment 
with LiOtBu induced the nucleophilic substitution. Selective lactam reduction with 
borane-THF complex originated the corresponding borane-amine complex from 
which the free base 3,9-diazatricyclo[5.3.0.01,5]decane 92 was liberated (Scheme 
1).1 
89 90 91
92
BnNH
2
THF
87%
MsCl, NEt
3;
LiOtBu
 
THF
92%
BH
3
.THF (THF)
NEt
3
 (EtOH/H
2
O)
94%
 
Scheme 1 
This work shows an example of further functionalization of the photoproducts 
as a way of obtaining highly functionalized molecules with potential use in complex 
organic chemistry synthesis. 
In extension to the work previously developed by Fort et al.1, a different 
approach towards the functionalization of 89 was performed which demonstrated the 
versatility of the photoproducts by introducing different functionalities. The goal was 
the synthesis of an electrophilic building block rather than a nucleophilic one like 92. 
However, all the intermediates used in the synthetic route can be considered useful 
compact modules. A route with classic and reliable procedures was proposed.  
The lactone ring of 89 was quantitatively opened using ammonia as a 
nucleophile. The scaffold 94 possesses an amide and a primary alcohol in cis 
configuration. For the sequential rearrangement the hydroxyl group was protected 
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with TBDPS to give 94. TBDPS was the favorable choice due to the fact that his quite 
a resistant protecting group but can be cleaved selectively. 
NH
3
MeOH
40 °C, 10 h
100%
TBDPSCl
imidazole
DMF
23 °C, 24 h
95%
89 93 94  
Scheme 2 
Through a successful Hoffman rearrangement the amide was converted to the 
amine protected with Cbz (95). Contrary to a standard Hoffman rearrangement that is 
perfomed under higly basic conditions, the utilization of PhI(OAc)2 allowed the 
reaction to occur under mild conditions. The use of a reagent with a hypervalent 
iodine allowed the oxidation of the carboxamide to the corresponding isocyanate that 
later was trapped with benzyl alcohol as nucleophile.  
9594
BnOH, PhI(OAc)
2
MeCN
23°C, 24 h 
85%
 
Scheme 3 
Cleavage of the TBDPS protecting group with TBAF, followed by the reaction 
with thionyl chloride followed by treatment with pyridine gave access to cyclic 
sulfamidite 97. The rather low yield of the deprotection reaction can be justified by the 
formation of a cyclic carbamate. Further oxidation with catalytic ruthenium chloride 
and sodium periodate gave access the cyclic sulfamidate 98. 
TBAF
THF
23 °C, 2 h
50%
i) SOCl
2
, -40 °C, 1 h
ii) Py, 23 °C, 12 h
MeCN
74%
NaIO
4
cat. RuCl
3
.H
2
O
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2
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23 °C
53%95 96
97 98
Scheme 4 
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Stable electrophilic building blocks are not widely available; however, this 
particular cyclic sulfamidate is an interesting example. Compact module 98 is a 
stable cyclic sulfamidate, which possesses two orthogonally protected nitrogen atoms 
allowing further selective functionalization. Of particular interest is the neopentylic 
carbon which is generally quite unreactive in substitution reactions but in the case of 
the sulfamidate 98 nicely set up for SN2 reaction due to its cyclic structure. The 
synthetic potential of the complex cyclic sulfamidate 98 is beyond that which has 
been described, therefore delivering a great number of future synthetic opportunities. 
 4.2 BACE1 inhibitors: 
An attempt to synthetize an active compound to be used as a BACE-1 inhibitor 
was made.  
The initial examples of BACE1 inhibitors originated from substrate and 
transition-state analysis design. The compounds that were originated by this method 
possessed a large polar surface area making them prohibitive for permeability of the 
blood-brain barriers. Due to its large active site, the search for BACE1 inhibitors and 
their optimization has proved to be challenging. Small molecule inhibitors can be 
optimized for potency and potentially developed to be brain permeable and orally 
bioavailable and therefore allow a versatility that peptide mimetics do not offer. 
Amidine or guanidine-containing moieties were identified early on to form an 
ideal hydrogen-bonding system with the catalytic aspartyl dyad in BACE1 active 
center.2 
BACE can be prepared in highly purified forms and several of three - 
dimensional (3D) structures in complexation with a variety of inhibitors have been 
solved to contribute to rational drug design. 
BACE belongs to the family of the aspartic proteases and therefore it’s 
catalytic center has a dyad of aspartate residues. At least eight specific pockets (S4-
S1 and S1’-S4’) appear to be required for binding of substrate to the active site. In 
general, the active site of BACE is dominated by hydrophobic residues. S4, S2 and 
S2’ are more hydrophilic and solvent exposed (Figure 1). 
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Figure 1: Simplified diagram of BACE1 active site 3 
There are two main regions in BACE1 that can undergo conformational 
changes. The first, a β-harpin structure spans residues 70~76 known as the flap and 
the second one is a deep cleft adjacent to the S3 pocket, often referred to as the S3 
subpocket. The conformational changes are highly dependent on the nature of the 
ligand. The flap is a region that can be potentially used in order to achieve selectivity 
between the two BACE isoforms 1 and 2. In the BACE2 flap there is a proline instead 
of tyrosine that rigidifies the structure. The fact that the BACE1 flap is more 
conformationally free may allow that a longer substituent can conduct a change in the 
BACE1 flap that would cost too much energy in the case of BACE2 and therefore 
lead to selectivity. Previous exploitation of the conformationally variable S3 had 
shown impressive gains of potency.4 
The prime site of BACE has shown to be less restricted than the non-prime 
pockets. The S1’ pocket is large enough to accommodate a cyclohexyl group 
however, in natural substrates it is often unoccupied.  
One of the main challenges of the synthesis of BACE1 inhibitors is the fact 
that the active site is highly conserved among BACE1 and BACE2 making it difficult 
achieving selectivity. Besides the similarity among BACE1 and BACE2 there are 
some aspartyl proteases expressed in other tissues of the organism with a similar 
active site that its inhibition can cause undesirable side effects.  
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4.2.1 Molecular modeling and de novo design 
One of the first highly potent and more drug-like small molecule non-peptide 
BACE1 inhibitors  described was a 2-aminothiazine derivative synthetized by the 
Japanese pharmaceutical company Shionogi® (Scheme 5).5 
108  
Scheme 5 
This compound shows good in vitro and in vivo activity and due to that soon 
became a reference compound for assays and molecular modeling. Through the 
years several x-rays structures were resolved of the BACE1 108 complex. Low 
selectivity towards BACE2 and hERG channel inhibition are two of the main factors 
why the compound 108 did not became a drug.  
Since then several pharmaceutical companies have been working in the 
synthesis of BACE1 inhibitors. In Figure 2 there is an overview of several “head 
groups” that were synthetized and described by several companies.2 
 
Figure 2: Overview of different “head groups” of BACE1 inhibitors that were described by 
several pharmaceutical companies. 
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The fact that several different companies have been working in the last years 
in the synthesis of BACE1 inhibitors reveals how complex the synthesis and 
discovery of active compounds is.  
Although several new molecules were synthesized since the discovery of 
compound 108, most of them failed to become a drug. In the present there is one 
compound, Verubecestat, from the pharmaceutical company Merck® in phase III 
clinical trials (Scheme 6). 
Verubecestat  
Scheme 6 
The similarities among compound 108 and verubecestat are easily noticeable. 
Amide bonds, specially the ones whose cleavage could lead to formation of anilines 
are known to not be the most stable and safe motifs in drug compounds. Thus, 
verubecestat has not shown high metabolic instability. 
The 2-aminothiazine and 2-aminooxazine moieties are present in a lot of 
active compounds and increase the activity due to the establishment of a double 
hydrogen bonding network with the aspartatic dyad. The amidine moiety is 
responsible to ensure selectivity over other proteases. 
Another interesting feature of compound 108 is the extended functionalization 
towards the S3 pocket with a 5-chloro-2-pyridyl residue. The 5-chloro penetrates 
deeply into the S3 pocket, and the nitrogen of the pyridyl forms a hydrogen bond with 
the amide and thereby is responsible for the alignment of the phenyl and pyridyl 
residues in an almost planar arrangement. The amide bond between the two 
aromatic heterocycles mimics the peptide bond present in the natural substrate 
forming a hydrogen bond with the glycine 291 of BACE1.  
With this information in hand and some more acquired from other known 
inhibitors the design of novel series of potential BACE1 inhibitors was performed. The 
2-aminothiazine or 2-aminooxazine moieties were kept due to the fact that these 
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have been shown to be important pharmacophores. The incorporation of a 
cyclobutane ring allowed the opportunity to have more exit vectors towards other 
pockets that are not explored in compound 108. Aiming at gain of activity and 
selectivity, a functionalization towards the flap region was desired. The tricyclic 
scaffolds obtained by the intramolecular [2+2]-PCA of substituted furanones have a 
pyrrolidine ring that would be conformationally placed towards the flap. The 
pyrrolidine ring also permitted further functionalization of the nitrogen in order to have 
different substituents. Since the natural substrate of BACE1 has an aromatic residue 
lodged in S1 pocket an aryl ring into that position could also be a key point of the 
activity of the head group. 
The synthesis of a head group of the type B was planned (Scheme 7). 
Type B
X= S or O
R=H, Me
 
Scheme 7 
Computational molecular modeling, using the software Moloc,6 was performed 
for the head group to check its conformation in the active site of BACE1. Figure 3 
consists of the image of the modulation of the oxazine head group and the 
methylated pyrrolidine nitrogen in green, aligned with the x-ray structure of the 
Shionogi compound 108 (1bfgy; in orange) in the BACE1 active site. 
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Figure 3: Computational molecular modeling image of the BACE1 active site and two ligands 
(orange: Shionogi compound (1bfgy); green: compound type B (with X=O and R= Me). 
With the model it is possible to determine that the nitrogen of the pyrrolidine 
ring cannot be functionalized with a large substituent because most likely it would 
collide with the surface of the protein. So a methyl group would be the ideal 
substituent due to its small size and low hydrophilicity. There is still the chance of 
functionalization of the arylic ring in the para-position to the fluorine. By 
functionalization of this position there is the possibility to move slightly towards the S3 
pocket. However, due to the different spatial conformation this functionalization would 
not go deeply into S3 pocket as the one in the Shionogi compound 108. 
After the information from computational molecular modeling was gathered the 
synthesis of the potential BACE1 inhibitors was planned. For that photoproducts 
previously described were used as starting point. 
4.2.2- Synthesis of potential BACE1 inhibitors 
The amidine moiety has been reported as a crucial functionality towards the 
activity in BACE1. To install the amidine group directly into the cyclobutane ring, the 
loss of one carbon atom was required. Regarding to this, a rearrangement of a 
suitable carboxylic acid derivative (e.g. amide via Hoffmann or hydrazide via Curtius 
rearrangement) to the correspondent amine was envisioned.7 
From the previously described photoproduct 76 (chapter 3) the lactone ring 
was opened. Initially ammonia was chosen as the nucleophile. A similar approach 
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used in the synthesis of the cyclic sulfamidate 96 was planned. The ring open with 
ammonia would lead to the correspondent amide that would be a part of a Hoffman 
rearrangement to form the carbamate. 
Although the ammonolysis of the lactone 89 was successful in the 2-fluor-
phenyl derivative 61 case it’s nucleophilic character was not strong enough (Scheme 
8). After 24 h there was no consumption of starting material 61. 
X
NH
3
MeOH
60 °C,  24 h
(seled tube)
61 61a  
Scheme 8 
Given that a stronger nitrogen nucleophile was required, hydrazine was 
considered as the way to go. From the corresponding hydrazide conversion towards 
the corresponding acyl azide was possible and therefore a Curtius rearrangement 
was planned to access the desired carbamate. Hydrazine has a higher nucleophilicity 
than ammonia due to the so called α-effect. This effect states that a presence of an 
adjacent (α) atom with lone pair of electrons increases the nucleophilic character of a 
molecule. This effect has been explained assuming that the alpha lone-pair and 
nucleophilic electron pair destabilize each other by electronic repulsion and thereby 
increase the ground state making it more reactive. 
Reaction between 61 and excess hydrazine hydrate in ethanol in a pressure 
tube at 60 °C gave access to the corresponding hydrazide derivative 99 in almost 
quantitative yield (Scheme 9).  
N
2
H
4
.H
2
O
EtOH
60 °C, 72 h
91%
61 99  
Scheme 9 
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In consideration to the rearrangement the hydroxyl group had to be protected 
to avoid side reactions. In the Curtius rearrangement there is formation of the 
isocyanate as an intermediate. The free hydroxyl group could react with the 
isocyanate forming a cyclic carbamate which would be extremely hard to cleave. The 
first choice for protecting group was the TBDPS group since it has shown good 
performance in similar derivatives. However, the protection reaction occurred with 
low yields most likely due to high steric hindrance.  
In an attempt to increase the yield of the transformation another protecting 
group was selected. A similar but yet less bulky option was found in the TBDMS 
group. The fact that the silyl ethers are easily formed and cleaved selectively under 
mild conditions are two of the most interesting characteristics of this family of 
protecting groups (Scheme 10). 
TBDMSCl, DIPEA,
DMAP
DCM
0°C- 23°C, 18 h
99%
99 100  
Scheme 10 
The following step was to convert the hydrazide into an acyl azide in the 
presence of the Boc group. Using a classic peptide synthesis procedure the 
conversion occurred with 76% yield on a reasonable scale.8 The acyl azide 101 was 
isolated and even chromatographed with no sign of decomposition (Scheme 11). 
HCl, NaNO
2
DMF
-5 °C, 
76%
100 101  
Scheme 11 
With the acyl azide 101 in hand the Curtius rearrangement to obtain the 
corresponding carbamate was performed (Scheme 12). Although formation of the 
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free amine is necessary for a later step, direct isolation of this compound would prove 
difficult. In addition access to the free amine via the Curtius rearrangement would 
require strongly basic conditions leading to cleavage of the TBDMS group. Instead, 
accessing the corresponding carbamate afforded two orthogonally protected 
nitrogens and facilitated isolation and purification processes.  
Mechanistically the Curtius rearrangement has two main parts: the formation 
of the isocyanate by refluxing the acyl azide in toluene followed by the carbamate 
formation in the presence of benzyl alcohol. Transformation form the acyl azide 101 
to the corresponding carbamate 102 was performed using just two equivalents of 
benzyl alcohol with a high yield (Scheme 12).  
  BnOH
PhMe
120 °C, 18 h
83%
101 102  
Scheme 12 
The rearrangement was performed in the presence of an alcohol to avoid 
reaction between the isocyanates, forming stable urea derivatives which would be 
hard to cleave. The choice of benzyl alcohol allowed cleavage by hydrogenolysis; 
conditions to which the Boc and TBDMS protecting groups are inert in this substrate. 
However the high boiling point of benzyl alcohol also played an important role.  
Cleavage of the Cbz group by hydrogenolysis provided the free amine in 
quantitative yield. As previously discussed the selectivity of the hydrogenolysis 
allowed that the pyrrolidine and the hydroxyl group remained protected. For the 
success of the synthesis of the thiourea it was crucial that the free amine was the 
only free functionality available to react with the benzoyl isothiocyanate. 
With just 1.05 equiv. of benzoyl isothiocyanate the thiourea 104 was smoothly 
synthetized in 91% yield (Scheme 13). 
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102 103 104
H
2
, Pd/C
EtOH, 
80 °C, 18 h
98%
BzNCS
THF
0°C-23°C, 5 h
91%
 
Scheme 13 
For both - the oxazine and the thiazine compounds - the TBDMS group was 
cleaved to give the free hydroxy thiourea 105.  
104 105
TBAF
THF 
0 °C, 2 h
92%
 
Scheme 14 
From scaffold 105 both oxazine and thiazine rings can be accessed. Although 
both compounds were interesting a set of reaction conditions that would be selective 
towards each one of the functional groups was desired. An initial set of experiments 
was performed.  
106105 107   
Scheme 15 
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Table 1: Optimization of selectivity of the synthesis of 106 vs 107. 
# s.m. Reaction conditions Reaction 
time 
Products Yield of 
(%) 
1 105 Tf2O, Py, DCM, -50 °C to 
-30 °C 
2 h 106 and 107 
(1:1) 
106-44% 
107-42% 
2 105 CBr4, PPh3, DCM, 0°C 2 h 106 and 107 
(3:1) 
106-77% 
107-22% 
3 105 Ghosez’s reagent, DCM, 
0 °C to 23 °C 
2.5 h 106 97% 
4 105 EDC, MeCN, 75 °C 1.5 h 107 98% 
 
First triflic anhydride, pyridine in dichloromethane was used and led to the 
formation of both the oxazine and the thiazine in a 1:1 ratio.9 The 1:1 ratio is due to 
the formation of both the STf and the OTf in the reaction mixture. In the case of the 
formation of the OTf there is formation of the thiazine and consequently the formation 
of STf as a leaving group gives the oxazine. 
In a second approach carbon tetrabromide, triphenylphosphine in 
dichloromethane also caused formation of both products in a 3:1 ratio in favor of the 
thiazine. Using carbon tetrabromide and triphenylphosphine it was expected that the 
phosphonium salt would activate the hydroxyl group. Therefore the bromine would be 
inserted in the hydroxyl position and act as a leaving group for the formation of the 
thiazine ring. However, there is also activation of the sulfur by the phosphonium salt, 
which leads to the formation of the oxazine ring. Due to the strong oxophilic character 
of phosphorous there is a preferential activation of the hydroxyl group. This justifies 
the higher ratio of thiazine formation. 
In the continuous search for selective conditions towards the thiazine a 
procedure using Ghosez’s reagent was performed. Mechanistically the Ghosez’s 
reagent would lead to the replacement of the hydroxyl group by chlorine. The 
chlorine would act as a leaving group leading to the formation of the thiazine. Using 
Ghosez’s reagent selectivity towards the thiazine synthesis was achieved.10  
In the attempt to obtain selective conditions towards the synthesis of the 
oxazine moiety, EDC was used as reagent. EDC captures the sulfur and forms a 
carbodiimine that is attacked by the oxygen of the hydroxyl group closing the oxazine 
ring.The reaction was conducted using acetonitrile reflux, and 1.5 hour later the 
oxazine 107 was synthesized with 98% yield. 
82 
 
In order to enable BACE1 binding the free amidine is required. The benzoyl 
group was cleaved using potassium carbonate in methanol at 55 °C (Scheme 16).  
K
2
CO
3
MeOH 
55 °C
106 X =S
107 X=O
109 X= S 57%
110 X= O 78%  
Scheme 16 
The next step consisted of cleaving the Boc group in order to have the free 
amines. The cleavage was performed by suspending the starting materials in a 4 M 
solution of HCl in dioxane and filtration of the HCl salt precipitate (Scheme 17). 
4 M HCl in dioxane
 
23 °C
109 X =S
110 X=O
111 X= S 56%
112 X= O 48%
 
Scheme 17 
The head groups with the free amidine moiety were submitted to an in vitro 
assay. The compounds submitted were all racemic mixtures because a chiral 
synthesis was not discovered in this case. It is known that most likely only one 
enantiomer will be active. If the racemic mixtures show activity in the biological 
assays the enantiomers can be separated by chiral HPLC. Further functionalization 
to achieve a variety of new compounds was planned. The free pyrrolidine group 
increases the basicity of the molecule. In the other hand the Boc group is most likely 
too large and would collide with the surface of the protein. The molecular modeling 
showed that the methyl group could be a good choice.  
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4.2.3 MR121 BACE assay and results 
The MR121 fluorescense assay is based on the fact that MR121 forms a non-
fluorescent ground state complex with tryptophan. This principle can be used to 
design biochemical assays for proteases. In absence of protease activity, the 
substrate remains intact, and the MR121 fluorescence is reduced by the high local 
Trp-concentration. If the substrate is cleaved by the enzyme the MR121 fluorescence 
is recovered. In our case the protease is the aspartic protease 6his-BACE1. The 
enzymatic reaction can be followed in a kinetic measurement detecting an increase 
of MR121 fluorescence during the reaction time. If the enzyme is inhibited there is no 
increase of the MR121 fluorescence. Calculating the slope in the linear range of the 
kinetic provides a robust value for the activity of 6his-BACE1. This assay principle is 
suitable for inhibitor screens, looking for compounds which decrease the activity and 
thus the slope.  
 
Figure 4: Schematic representation of the principle of an MR121 BACE assay. 
In order to evaluate the binding activity of the head groups 109, 110 and 111 
this groups were submitted to the MR121 BACE1 (Table 2). Head group 112 was not 
submitted early enough so the results were obtained to be part of this dissertation. 
Table 2: Results of the MR121 BACE assays. 
# Compound no. BACE1 IC50 BACE2 IC50 
1 109 >200 (μM) >200 (μM) 
2 110 >200 (μM) >200 (μM) 
3 111 >200 (μM) >200 (μM) 
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The results of the MR121 showed that the head groups have no inhibition 
activity towards BACE1 or BACE2. With an IC50 of over 200 μM in the MR121 the 
compounds do not show promising potential to become BACE1 inhibitors. The lack of 
activity of compounds 109 and 110 was expected due to the fact that the Boc group 
on the pyrrolidine ring would be too bulky and collapse against the surface of the 
protein. The lack of activity of compound 111 can be explained by the high basicity of 
the free amine and amidine moieties that can compromise binding. Another 
explanation is that the pyrrolidine ring is just too big itself to fit in the active site of 
BACE. In order to try to understand the lack of activity further decoration of the head 
group was planned.  
Further functionalization of the aryl ring has proven to be important in binding 
and selectivity towards BACE1. A methyl group would be small enough to fit in the 
active site without colliding with the surface of the active center. Several studies have 
showed that the functionalized pyridine group with the extension towards the S3 
pocket has increased the selectivity. However, the head group conformation showed 
that such a big substituent would not fit since it would not be oriented towards the S3 
pocket. (Scheme 18). 
X= S or O  
Scheme 18 
The first set of experiments will consist in the methylation of pyrrolidinic 
nitrogen followed functionalization of the phenyl ring with a small heterocyclic 
rotasymmetric substituent. Parallel to the attempts of increasing activity by 
functionalization of the head groups the synthesis of similar derivatives without the 
pyrrolidine group is being conducted. This set of experiments will help to determine if 
the pyrrolidine group is the cause of lack of activity. 
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4.3-Conclusion 
A novel electrophilic building block was successfully synthesized. The [2+2]-
PCA was crucial to stablish the cyclobutane moiety with the right regioselectivity. The 
versatility of photoproduct 89 was once again demonstrated. The exit vectors of the 
tricyclic moiety were successfully functionalized to obtain another complex and novel 
compact module.  
Cyclic sulfamidate 98 is a stable electrophilic building block with a set of 
characteristics that provide an enormous synthetic versatility that is rarely found in 
such complex scaffolds. The two orthogonally protected nitrogens, the stable 
sulfamidate and the reactive neopentylic carbon provide several opportunities of 
decoration to achieve higher levels of complexity.  
In recent years several technological advances have been achieved towards 
the optimization of computational chemistry. One of the biggest challenges is the 
accurate calculation of absolute free energies of binding. The underlying physics of a 
protein are best computed using rigorous statistical mechanisms methods. However, 
perfect prediction of protein-ligand interactions is not possible. In vivo and in vitro 
assays sometimes have completely different outcomes from what the computational 
chemistry predicted. This was demonstrated in the case of the head groups 109, 110 
and 111. Although the compounds should have high probability of activity according 
to computational modeling in the in vitro assay the compounds showed to be inactive. 
Methylation of the pyrrolidinic nitrogen as well as functionalization of the arylic ring 
may cause increase of the activity. 
Despite being inactive the novel head groups have a tricyclic moiety with a 
cyclobutane ring that has never been reported as potential BACE1 inhibitors. The 
topology of the cyclobutane ring forces the ligand into a conformation allowing the 
exploration of the S2 region and S2’ pocket. Several approaches of functionalization 
of the cyclobutane ring are innovative and hopefully will be groundbreaking in the 
synthesis of BACE1 inhibitors. 
The large number of companies and the time spent in BACE1 inhibitors 
research illustrate the dimension of the challenge. Several in vitro highly active 
compounds have been described however, most of them showed no in vivo activity. 
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Blood Brain barrier penetration as well as Pgp efflux continue to be the main 
challenges in the design of BACE1 inhibitors. Other problems are related with safety 
risks because selectivity towards closely related aspartyl proteases is required in 
order to avoid several secondary effects.  
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4.4-Experimental section: 
General: Unless otherwise stated, the reactions were stopped when the starting 
material was fully consumed according to thin layer chromatography (TLC) and/or 
LC/MS analysis. Compounds were detected by UV (λ=254 nm), CAM (cerium 
ammonium molybdate solution) or KMnO4. 
1H and 13C NMR: Bruker AV-300, AV-400 
and AV-600 recorded at 300 K unless otherwise indicated. Chemical shifts are 
reported relative to the solvent [CHCl3: δ (
1H) =7.26 ppm, δ (13C) = 77.0 ppm, DMSO 
δ (1H) =2.50 ppm, δ (13C) = 39.5 ppm] as reference. The relative configuration of the 
products was determined by two-dimensional NMR spectra (COSY, NOESY, HSQC, 
HMBC). HRMS data were recorded by electron spray ionization (ESI) on an ion trap 
mass spectrometer. 
(1SR,5RS,7RS)-tert-Butyl-7-carbamoyl-1-(hydroxymethyl)-3-
azabicyclo[3.2.0]heptane-3-carboxylate (93): 
In a pressure tube, a mixture of (3aRS,4aRS,7aSR)-tert-
butyl 3-oxohexahydrofuro[3',4':1,4]cyclobuta[1,2-c]pyrrole-6(1H)-
carboxylate (6 g, 23.7 mmol, equiv: 1.0) and ammonia (7 M in 
methanol) (49.1 mL, 343 mmol, equiV: 14.5) was stirred at 40 °C 
for 24 h. All volatiles were removed in vacuum to give the 
(1SR,5RS,7RS)-tert-butyl7-carbamoyl-1-(hydroxymethyl)-3-azabicyclo[3.2.0]heptane-
3-carboxylate (6.4 g, 100 % yield) as a white foam. 
1H NMR (600 MHz, DMSO) δ ppm 1.42 (s, 9 H), 1.49-1.57 (m, 1 H), 2.32-2.49 (m, 2 
H), 2.78-2.84 (m, 1 H), 3.13-3.27 (m, 2 H), 3.37-3.57 (m, 4 H), 4.66 (s, 1 H), 6.81 (s, 
1 H), 7.24 (s, 1 H). 
(1SR,5RS,7RS)-tert-Butyl 1-(((tert-butyldiphenylsilyl)oxy)methyl)-7-carbamoyl-3-
azabicyclo[3.2.0]heptane-3-carboxylate (94): 
 (1SR,5RS,7RS)-tert-Butyl 7-carbamoyl-1-
(hydroxymethyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate (4.48 
g, 16.6 mmol, equiv: 1.0) was combined with DMF (22.1 mL). 
Imidazole (1.69 g, 24.9 mmol, equiv: 1.5) was added. Dropwise 
addition of TBDPS-Cl (5.47 g, 5.11 mL, 19.9 mmol, equiv: 1.2) 
and the reaction mixture was stirred at 23 °C during 18 h. The reaction mixture was 
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extracted with EtOAc and water. The organic layers were collected and dried over 
Na2SO4. All volatiles were removed under vacuum. The crude material was purified 
by flash chromatography (silica gel, 40 g, 0% to 80% EtOAc in heptane). The major 
fraction was collected to give as a white crystal (1SR,5RS,7RS)-tert-butyl 1-(((tert-
butyldiphenylsilyl)oxy)methyl)-7-carbamoyl-3-azabicyclo[3.2.0]heptane-3-carboxylate 
(7.286 g, 86% yield). 
1H NMR (600 MHz, DMSO) δ ppm 0.88-1.06 (m, 9 H), 1.43 (s, 9 H), 151-1.66 (m, 1 
H), 2.38 (ddd, J=11.9, 9.1, 7.4 Hz, 1 H), 2.52-2.55 (m, 1 H), 2.83 (t, J= 8.0 Hz, 1 H) 
3.29 (dd, J= 11.4, 7.3 Hz, 2 H) 3.42 (d, J= 11.3 Hz, 1 H), 3.51-3.87 (m, 3 H), 6.77 (s, 
1 H), 7.12-7.32 (m, 1 H), 7.38-7.69 (m, 10 H) 
HRMS m/z=409.230 [(M+H)+(-Boc)]+ calculated from C29H40N2O4Si (M=508.2768) 
(1RS,5RS,7RS)-tert-Butyl 7-(((benzyloxy)carbonyl)amino)-1-(((tert-
butyldiphenylsilyl)oxy)methyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate (95): 
A solution of (1SR,5RS,7RS)-tert-butyl 1-(((tert-
butyldiphenylsilyl)oxy)methyl)-7-carbamoyl-3-
azabicyclo[3.2.0]heptane-3-carboxylate (7.286 g, 14.3 mmol, 
equiv: 1.0) in acetonitrile (57.3 mL) was stirred at 23 °C. Benzyl 
alcohol (3.1 g, 2.98 mL, 28.6 mmol, equiv: 2.0) was added, and 
the mixture was stirred. The reaction was cooled down to 0 °C with an ice bath, and 
iodobenzene diacetate (5.07 g, 15.8 mmol, equiv: 1.1) was added carefully. The 
reaction was stirred overnight at 23 °C. The organic layer was extracted with TBME 
and water and NaCl. The organic layers were collected and dried over Na2SO4. All 
volatiles were removed under vacuum. The crude material was purified by flash 
chromatography (silica gel, 40 g, 0% to 50% EtOAc in heptane) to give 
(1RS,5RS,7RS)-tert-butyl 7-(((benzyloxy)carbonyl)amino)-1-(((tert-
butyldiphenylsilyl)oxy)methyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate (5.74 g, 65% 
yield) as a colorless oil.  
1H NMR (600 MHz, CDCl3) δ ppm 1.02-1.16 (m, 6 H), 1.20-1.32 (m, 1 H), 1.37-1.55 
(m, 6 H), 2.06-2.25 (m, 1 H), 2.76 (s, 2 H), 3.15-3.91 (m, 4 H), 4.29 )q, J=8.2 Hz, 1 
H), 4.57-4.73 (m, 4 H), 4.95-5.19 (m, 1 H), 5.87 (s, 1 H), 7.27-7.51 (m, 13 H), 7.55-
7.75 (m, 3 H) 
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HRMS m/z= 637.3075 [M+Na]+ calculated from C36H46N20O5Si (M=614.3179) 
 
(1RS,5RS,7RS)-tert-Butyl 7-(((benzyloxy)carbonyl)amino)-1-(hydroxymethyl)-3-
azabicyclo[3.2.0]heptane-3-carboxylate (96): 
A solution of (1RS,5RS,7RS)-tert-butyl 7-
(((benzyloxy)carbonyl)amino)-1-(((tert-butyldiphenylsilyl)oxy)methyl)-
3-azabicyclo[3.2.0]heptane-3-carboxylate (5.74 g, 9.34 mmol, equiv: 
1.0) in TBAF (9.34 mL, 9.34 mmol, equiv: 1.0) was stirred at 23 °C 
during 2 h. The reaction was extracted with water and EtOAc, the organic layers were 
collected and dried over Na2SO4. All volatiles were removed under vacuum. The 
crude material was purified by flash chromatography (silica gel, 80 g, 0% to 100% 
EtOAc in heptane). The bottom spot was isolated and identified as (1RS,5RS,7RS)-
tert-butyl 7-(((benzyloxy)carbonyl)amino)-1-(hydroxymethyl)-3-
azabicyclo[3.2.0]heptane-3-carboxylate (1.91 g, 54% yield), as a colorless oil. 
1H NMR (600 MHz, CDCl3) δ ppm 1.47 (s, 9 H), 1.98 (s, 1 H), 2.18 (s, 1 H), 2.39 (s, 1 
H), 2.57 (s, 1 H), 3.12 (d, J=10.0 Hz, 1 H), 3.29-3.75 (m, 4 H), 3.81 (s, 1 H), 4.03-
4.25 (m, 1 H), 4.98-5.19 (m, 2 H), 5.38 (s, 1 H), 7.30-7.49 (m, 5 H). 
HRMS m/z =321.1447 [(M+H)+-(-C4H8)] calculated from C20H28FN2O5 (M=376.2013) 
 (4aRS,5aRS,8aRS)-4-Benzyl 7-tert-butyl 
tetrahydropyrrolo[3',4':2,3]cyclobuta[1,2-d][1,2,3]oxathiazine-4,7(1H,8H)-
dicarboxylate 3-oxide (97): 
To a solution of thionyl chloride (1.51 g, 926 µl, 12.7 mmol, 
equiv: 2.5) in acetonitrile (22.3 mL) at -40 °C was dropwise a 
solution of (1RS,5RS,7RS)-tert-butyl 7-
(((benzyloxy)carbonyl)amino)-1-(hydroxymethyl)-3-
azabicyclo[3.2.0]heptane-3-carboxylate (1.91 g, 5.07 mmol, equiv: 
1.0) in acetonitrile (4.45 mL), the mixture was stirred at -40 °C for 1 h, then pyridine 
(2.01 g, 2.05 mL, 25.4 mmol, equiv: 5.0) was added dropwise, and the reaction was 
allowed to warm to 23 °C and stirred for 20 h. All volatiles were removed in vacuum, 
added diethyl ether, the solid was filtered off, the organic layer was washed with 0.5 
M HCl and brine, dried over Na2SO4. Filtration and removal of the solvent in vacuum 
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left the crude (4aRS,5aRS,8aRS)-4-benzyl 7-tert-butyl 
tetrahydropyrrolo[3',4':2,3]cyclobuta[1,2-d][1,2,3]oxathiazine-4,7(1H,8H)-
dicarboxylate 3-oxide (1.87 g, 87.2 % yield) as a light yellow oil which was used 
without further purification.
 
(4aRs,5aRS,8aRS)-4-Benzyl-7-tert-butyl 
tetrahydropyrrolo[3',4':2,3]cyclobuta[1,2-d][1,2,3]oxathiazine-4,7(1H,8H)-
dicarboxylate 3,3-dioxide (98): 
To a solution of (4aRS,5aRS,8aRS)-4-benzyl 7-tert-butyl 
tetrahydropyrrolo[3',4':2,3]cyclobuta[1,2-d][1,2,3]oxathiazine-
4,7(1H,8H)-dicarboxylate 3-oxide (1.87 g, 4.43 mmol, equiv: 1.0) in 
ethyl acetate (12.6 mL), acetonitrile (12.6 mL) and water (19 mL) at 5 
°C was added sodium periodate (1.42 g, 6.64 mmol, equiv: 1.5) 
followed by ruthenium(II) chloride hydrate (9.98 mg, 44.3 µmol, equiv: 0.01) and the 
mixture was stirred at 23 °C for 1.75 h. Poured into water, extracted with EtOAc, the 
organic layer was washed with brine. The organic layers were collected and dried 
over Na2SO4. All volatiles were removed under vacuum. The crude material was 
purified by flash chromatography (silica gel, 100 g, 0% to 100% EtOAc in heptane) to 
give the (4aRs,5aRS,8aRS)-4-benzyl 7-tert-butyl 
tetrahydropyrrolo[3',4':2,3]cyclobuta[1,2-d][1,2,3]oxathiazine-4,7(1H,8H)-
dicarboxylate 3,3-dioxide (1.19 g, 61.3 % yield) as a white foam. 
1H NMR (600 MHz, CDCl3) δ ppm 1.47 (s, 9 H), 2.18-2.65 (m, 2 H), 2.91 (d, J=12.0 
Hz, 2 H), 3.39-3.78 (m, 3 H), 4.47-4.79 (m, 2 H), 4.91 (t, J= 8.2 Hz, 1 H), 5.26-5.41 
(m, 3 H) 
HRMS m/z= 483.1425 [M+HCOO]- calculated from C20H26N2O7S (M=438.1429) 
(1S,5R,7R)-tert-Butyl 7-(2-fluorophenyl)-7-(hydrazinecarbonyl)-1-
(hydroxymethyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate (99): 
In 20mL pressure tubes, (3aRS4aRS,7aSR)-tert-butyl 3a-
(2-fluorophenyl)-3-oxohexahydrofuro[3',4':1,4]cyclobuta[1,2-
c]pyrrole-6(1H)-carboxylate (15.84 g, 45.6 mmol, equiv: 1.0) was 
combined with ethanol (76 mL). Hydrazine hydrate (14.3 g, 13.8 
mL, 182 mmol, equiv: 4.0) was added. The mixture was stirred 
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during 72 h at 60 °C. The solvents were evaporated. Extracted with water and 
EtOAc, dried over Na2SO4, filtered off and evaporated totally (18.2 g yellow foam). 
Trituration with dichloromethane and diethyl ether stirred for 10 minutes and filtered 
off the crystals. Washed with diethyl ether and dried in HV to give 13.57 g white 
crystals. The organic layers were collected and dried over Na2SO4. All volatiles were 
removed under vacuum. The crude material was purified by flash chromatography 
(silica gel, 50 g, 0% to 100% EtOAc in heptane). The product fractions were 
combined and totally evaporated to give (1S,5R,7R)-tert-Butyl 7-(2-fluorophenyl)-7-
(hydrazinecarbonyl)-1-(hydroxymethyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate 
(2.17 g, 91% yield) as a light yellow foam. 
1H NMR (600 MHz, DMSO) δ ppm 1.22 (s, 6 H), 1.34 (s, 10 H), 1.79-1.94 (m, 2 H), 
2.17-2.22 (m, 1 H), 2.68-2.76 (m, 1 H), 2.71-2.76 (m, 1 H), 3.05-3.14 (m, 2 H), 3.22 
(s, 3 H), 3.23-3.28 (m, 2 H), 3.30-3.31 (m, 1 H), 3.44-3.49 (m, 2 H), 3.47-3.52 (m, 1 
H), 3.57 (d, J= 4.9 Hz, 2 H), 3.58 (d, J=5.1 Hz, 1 H), 4.29 (s, 4 H), 4.95 (d, J=18.2 Hz, 
2 H), 7.10-7.15 (m, 2 H), 7.13-7.21 (m, 1 H), 7.28 (s, 1 H), 7.29-7.40 (m, 2 H), 8.09-
8.35 (m, 2 H) 
HRMS m/z =380.1977 [M+H]+ calculated from C19H26FN3O4 (M=379.1903) 
 (1S,5R,7R)-tert-Butyl 7-(2-fluorophenyl)-7-(hydrazinecarbonyl)-1-
(hydroxymethyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate (100):
 
To a solution of (1SR,5RS,7RS)-tert-butyl 7-(2-
fluorophenyl)-7-(hydrazinecarbonyl)-1-(hydroxymethyl)-3-
azabicyclo[3.2.0]heptane-3-carboxylate (5.34 g, 14.1 mmol, 
equiv: 1), DIPEA (2.55 g, 3.44 mL, 19.7 mmol, equiv: 1.4), 
DMAP (172 mg, 1.41 mmol, equiv: 0.1) in dichloromethane 
(28.1 mL) at 0 °C, TBDMS-Cl (2.55 g, 16.9 mmol, equiv: 1.2) 
was added, and the mixture was stirred at 0 °C, slowly warming up until 23 °C for 18 
hours. Poured into NH4Cl and extracted with dichloromethane. The organic layers 
were washed with water and brine, The organic layers were collected and dried over 
Na2SO4. All volatiles were removed under vacuum. The crude material was purified 
by flash chromatography (silica gel, 12 g, 0% to 50% EtOAc in heptane) to give 
(1SR,5RS,7RS)-tert-butyl 1-(((tert-butyldimethylsilyl)oxy)methyl)-7-(2-fluorophenyl)-7-
92 
 
(hydrazinecarbonyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate (5.27 g, 76% yield) as 
a colorless oil. 
1H NMR (600 MHz, DMSO) δ ppm 0.00 (t, J=5.5 Hz, 6 H) 0.81 (br d, J=8.0 Hz, 9 H) 
1.12 -1.34 (m, 10 H) 1.75 - 1.98 (m, 1 H) 2.62 - 2.80 (m, 1 H) 2.95 - 3.23 (m, 3 H) 
3.39 - 3.61 (m, 2 H) 3.74 (br dd, J=17.1, 10.2 Hz, 1 H) 4.33 (br s, 2 H) 6.95 - 7.39 (m, 
4 H) 7.69 - 8.61 (m, 1 H) 
HRMS m/z =494.2831 [M+H]+ calculated from C25H40FN3O4Si (M=493.2753) 
 (1SR,5RS,7RS)-tert-Butyl 7-(azidocarbonyl)-1-(((tert-
butyldimethylsilyl)oxy)methyl)-7-(2-fluorophenyl)-3-azabicyclo[3.2.0]heptane-3-
carboxylate (101): 
A solution of (1SR,5RS,7RS)-tert-butyl 1-(((tert-
butyldimethylsilyl)oxy)methyl)-7-(2-fluorophenyl)-7-
(hydrazinecarbonyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate 
(4.77 g, 9.66 mmol, equiv: 1.0) in DMF (47.4 mL) is cooled to - 
5 °C while HCl (9.66 mL, 38.6 mmol, equiv: 4.0) is added with 
stirring. This is followed by the addition of a precooled mixture 
of sodium nitrite (2.32 mL, 11.6 mmol, equiv: 1.2) and DMF (47.4 mL). Five minutes 
later the excess of HCl is neutralized with triethylamine (2.54 g, 3.5 mL, 25.1 mmol, 
equiv: 2.6) and the solution is dried briefly over Na2SO4. The organic layer was 
extracted with ice cold water and EtOAc. The organic layers were collected and dried 
over Na2SO4. All volatiles were removed under vacuum. The crude material was 
purified by flash chromatography (silica gel, 12 g, 0% to 70% EtOAc in heptane) to 
give (1SR,5RS,7RS)-tert-butyl 7-(azidocarbonyl)-1-(((tert-
butyldimethylsilyl)oxy)methyl)-7-(2-fluorophenyl)-3-azabicyclo[3.2.0]heptane-3-
carboxylate (3.68 g, 76% yield) as a colorless oil. 
1H NMR (600 MHz, CDCl3) δ ppm 0.05 - 0.15 (m, 6 H) 0.84 - 0.99 (m, 9 H) 1.26 - 
1.46 (m, 8 H) 1.97 - 2.14 (m, 1 H) 2.33 -4.14 (m, 8 H) 6.77 - 7.43 (m, 5 H) 
HRMS m/z =421.1948 [(M+H)+(-C4H8N2)] calculated from C25H37FN4O4Si 
(M=450.2717) 
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(1RS,5RS,7RS)-tert-Butyl 7-(((benzyloxy)carbonyl)amino)-1-(((tert-
butyldimethylsilyl)oxy)methyl)-7-(2-fluorophenyl)-3-azabicyclo[3.2.0]heptane-3-
carboxylate (102): 
Dissolve (1SR,5RS,7RS)-tert-butyl 7-(azidocarbonyl)-1-
(((tert-butyldimethylsilyl)oxy)methyl)-7-(2-fluorophenyl)-3-
azabicyclo[3.2.0]heptane-3-carboxylate (123 mg, 244 µmol, 
equiv: 1.0) in toluene (975 µl) and heat at 120 °C and stir for 2 
hours. Add benzyl alcohol (52.7 mg, 50.7 µl, 487 µmol, equiv: 
2.0) and stir overnight All volatiles were removed under 
vacuum. The crude material was purified by flash chromatography (silica gel, 12 g, 
0% to 100% EtOAc in heptane). In the 1H NMR traces of benzyl alcohol was still 
visible. The major fraction was collected as (1RS,5RS,7RS)-tert-butyl 7-
(((benzyloxy)carbonyl)amino)-1-(((tert-butyldimethylsilyl)oxy)methyl)-7-(2-
fluorophenyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate (141 mg, 99% yield) as an 
orange oil. 
1H NMR (600 MHz, CDCl3) δ ppm 0.06 - 0.19 (m, 6 H) 0.91 (br s, 9 H) 1.31 (s, 4 H) 
1.41 (s, 5 H) 2.30 - 3.76 (m, 8 H) 4.20 - 4.36 (m, 1 H) 4.70 (s, 2 H) 4.84 (br d, J=12.3 
Hz, 1 H) 5.02 (br d, J=12.3 Hz, 1 H) 6.91 - 7.04 (m, 1 H) 7.06 - 7.18 (m, 1 H) 7.28 - 
7.32 (m, 3 H) 7.34 - 7.39 (m, 4 H) 7.40 - 7.51 (m, 1 H) 7.75 - 8.35 (m, 1 H) 
 
LC/MS (ESI) m/z =585.315 [M+H]+ calculated from C32H45FN2O5Si (M=584.308) 
 (1RS,5RS,7RS)-tert-Butyl 7-amino-1-(((tert-butyldimethylsilyl)oxy)methyl)-7-(2-
fluorophenyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate (103): 
A solution of (1R,5R,7R)-tert-butyl 7-
(((benzyloxy)carbonyl)amino)-1-(((tert-
butyldimethylsilyl)oxy)methyl)-7-(2-fluorophenyl)-3-
azabicyclo[3.2.0]heptane-3-carboxylate (3.51 g, 6 mmol, equiv: 
1) with palladium on carbon (639 mg, 600 µmol, equiv: 0.1) in 
ethanol (600 mL) was hydrogenated at 23 °C for 1 hour in a 
pressure tube. The catalyst was filtrated and the volatiles were removed under 
vacuum. To give (1RS,5RS,7RS)-tert-butyl 7-amino-1-(((tert-
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butyldimethylsilyl)oxy)methyl)-7-(2-fluorophenyl)-3-azabicyclo[3.2.0]heptane-3-
carboxylate (2.66 g, 98% yield) as a colorless oil. 
1H NMR (600 MHz, CDCl3) δ ppm 0.07 - 0.15 (m, 6 H) 0.92 (br d,J=8.9 Hz, 10 H) 
1.27 - 1.45 (m, 9 H) 2.31 (br d,J=8.3 Hz, 2 H) 2.71 - 2.93 (m, 1 H) 3.13 - 3.49 (m, 4 
H) 3.53 - 4.28 (m, 2 H) 3.65 - 3.65 (m, 1 H) 5.30 (s, 1 H) 6.82 - 7.25 (m, 3 H) 7.31 - 
7.52 (m, 1 H) 
HRMS m/z =451.2791 [M+H]+ calculated from C24H39FN2O4Si (M=450.2717) 
(1RS,5RS,7RS)-tert-Butyl 7-(3-benzoylthioureido)-1-(((tert-
butyldimethylsilyl)oxy)methyl)-7-(2-fluorophenyl)-3-azabicyclo[3.2.0]heptane-3-
carboxylate (104): 
 To a solution of (1RS,5RS,7RS)-tert-butyl 7-amino-1-
(((tert-butyldimethylsilyl)oxy)methyl)-7-(2-fluorophenyl)-3-
azabicyclo[3.2.0]heptane-3-carboxylate (2.66 g, 5.9 mmol, 
equiv: 1) in THF (148 mL) at 0 °C add benzoyl isothiocyanate 
(1.01 g, 833 µl, 6.2 mmol, equiv: 1.05). Remove the ice bath 
and let it heat up until 23 °C. Stir at 23 °C during 5 hours 
(consumption of starting material verified in TLC). All volatiles were removed under 
vacuum. The crude material was purified by flash chromatography (silica gel, 100 g, 
0% to 30% EtOAc in heptane) to give a clean fraction (3.3g) (1RS,5RS,7RS)-tert-
butyl 7-(3-benzoylthioureido)-1-(((tert-butyldimethylsilyl)oxy)methyl)-7-(2-
fluorophenyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate (3.3 g, 91% yield) as a white 
solid  
1H NMR (600 MHz, DMSO) δ ppm -0.02 - 0.03 (m, 5 H) 0.77 (br s, 9 H) 1.01 - 1.09 
(m, 5 H) 1.19 (br s, 3 H) 2.56 (br s, 1 H) 2.73 (br s, 1 H) 2.88 (br s, 1 H) 2.95 (br 
d,J=9.9 Hz, 1 H) 3.04 (br s, 1 H) 3.10 - 3.15 (m, 1 H) 3.27 - 3.34 (m, 1 H) 4.00 (br s, 1 
H) 6.96 - 7.03 (m, 1 H) 7.01 (br s, 1 H) 7.13 - 7.22 (m, 1 H) 7.36 - 7.40 (m, 2 H) 7.45 - 
7.49 (m, 1 H) 7.50 (br dJ,=7.3 Hz, 1 H) 7.78 (br d,J=7.3 Hz, 2 H) 10.94 (br s, 1 H) 
11.84 (br s, 1 H) 
 
HRMS m/z =612.273 [M-H]- calculated from C32H44FN3O4SSi (M=613.281) 
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(1RS,5RS,7RS)-tert-Butyl 7-(3-benzoylthioureido)-7-(2-fluorophenyl)-1-
(hydroxymethyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate (105): 
 A solution of (1RS,5RS,7RS)-tert-butyl 7-(3-
benzoylthioureido)-1-(((tert-butyldimethylsilyl)oxy)methyl)-7-(2-
fluorophenyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate (3.3 g, 
5.38 mmol, equiv: 1.0) in THF (24 mL) and TBAF (5.91 mL, 
5.91 mmol, equiv: 1.1) was stirred at 0 °C during 2 hours. The 
reaction was extracted with water and EtOAc, The organic 
layers were collected and dried over Na2SO4. All volatiles were removed under 
vacuum. The crude material was purified by flash chromatography (silica gel, 40 g, 
0% to 50% EtOAc in heptane) to give (1RS,5RS,7RS)-tert-butyl 7-(3-
benzoylthioureido)-7-(2-fluorophenyl)-1-(hydroxymethyl)-3-azabicyclo[3.2.0]heptane-
3-carboxylate (2.47 g, 92% yield) as an light yellow foam. 
1H NMR (600 MHz, DMSO) δ ppm 0.97 - 1.58 (m, 10 H) 2.59 - 2.82 (m, 2 H) 2.94 - 
3.17 (m, 3 H) 3.45 (br d J,=11.0 Hz, 1 H) 3.71 - 4.17 (m, 2 H) 5.19 (br s, 1 H) 7.03 - 
7.40 (m, 3 H) 7.50 (t, J=7.8 Hz, 2 H) 7.54 - 7.61 (m, 1 H) 7.60 - 7.66 (m, 1 H) 7.91 (br 
d, J=7.7 Hz, 2 H) 11.04 (br s, 1 H) 12.00 (br s, 1 H) 
HRMS m/z =500.1982 [M+H]+ calculated from C26H30FN3O4S (M=499.1910) 
 (4aRS,5aRS,8aRS)-tert-Butyl 3-benzamido-4a-(2-fluorophenyl)-4a,5,5a,6-
tetrahydro-1H-pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]oxazine-7(8H)-carboxylate 
(107): 
To a solution of (1RS,5RS,7RS)-tert-butyl 7-(3-
benzoylthioureido)-7-(2-fluorophenyl)-1-(hydroxymethyl)-3-
azabicyclo[3.2.0]heptane-3-carboxylate (100 mg, 200 µmol, 
equiv: 1.0) in acetonitrile (1 mL), EDC (57.6 mg, 300 µmol, 
equiv: 1.5) was added. The mixture was stirred at 65 °C during 
30 min (TLC showed little conversion) and the temperature 
was raised until 75 °C during 45 min. The volatiles were removed. The crude material 
was purified by flash chromatography (silica gel, 12 g, 0% to 50% EtOAc in heptane) 
to give (4aRS,5aRS,8aRS)-tert-butyl 3-benzamido-4a-(2-fluorophenyl)-4a,5,5a,6-
tetrahydro-1H-pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]oxazine-7(8H)-carboxylate (91 
mg, 98% yield) as a colorless oil. 
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1H NMR (600 MHz, DMSO) δ ppm 1.02 - 1.51 (m, 16 H) 2.52 - 2.64 (m, 2 H) 2.93 - 
3.18 (m, 3 H) 3.43 - 3.63 (m, 1 H) 4.29 - 4.58 (m, 2 H) 7.12 - 7.59 (m, 10 H) 8.03 (br 
d, J=7.5 Hz, 2 H) 11.01 - 11.81 (m, 1 H) 
 
LC/MS (ESI) m/z =466.214 [M+H]+ calculated from C26H28FN3O4 (M=465.206) 
 (4aS,5aR,8aR)-tert-butyl 3-benzamido-4a-(2-fluorophenyl)-4a,5,5a,6-tetrahydro-
1H-pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]thiazine-7(8H)-carboxylate (106): 
 To a solution of (1RS,5RS,7RS)-tert-butyl 7-(3-
benzoylthioureido)-7-(2-fluorophenyl)-1-(hydroxymethyl)-3-
azabicyclo[3.2.0]heptane-3-carboxylate (100 mg, 200 µmol, 
equiv: 1.0) in dichloromethane (1 mL) at 0 °C was added -chloro-
N,N,2-trimethylpropenylamine (29.4 mg, 29.1 µL, 220 µmol, 
equiv: 1.1) and the mixture was allowed to reach 23 °C and 
stirred for 2h. After 2h there was no total conversion so 1-chloro-N,N,2-
trimethylpropenylamine (29.4 mg, 29.1 µL, 220 µmol, equiv: 1.1) was added at 0 °C 
and let warm up until 23 °C. Added water and the reaction was extracted with EtOAc 
The organic layers were collected and dried over Na2SO4. All volatiles were removed 
under vacuum. The crude material was purified by flash chromatography (silica gel, 
12 g, 0% to 50% EtOAc in heptane) to give (4aS,5aR,8aR)-tert-butyl 3-benzamido-
4a-(2-fluorophenyl)-4a,5,5a,6-tetrahydro-1H-pyrrolo[3',4':2,3]cyclobuta[1,2-
d][1,3]thiazine-7(8H)-carboxylate (93 mg, 96.5 % yield) as a colorless oil  
1H NMR (600 MHz, DMSO) δ ppm 1.03 - 1.20 (m, 8 H) 1.22 - 1.27 (m, 1 H) 1.34 (br 
s, 5 H) 2.67 - 2.80 (m, 1 H) 2.87 - 3.25 (m, 3 H) 3.43 - 3.59 (m, 1 H) 7.18 - 7.31 (m, 3 
H) 7.36 - 7.47 (m, 4 H) 7.49 - 7.57 (m, 2 H) 7.87 - 8.00 (m, 2 H) 10.04 - 11.15 (m, 1 
H) 
HRMS m/z =482.1933 [M+H]+ calculated from C26H28FN3O3S (M=481.1854) 
 (4aRS,5aRS,8aRS)-tert-Butyl 3-amino-4a-(2-fluorophenyl)-4a,5,5a,6-tetrahydro-
1H-pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]oxazine-7(8H)-carboxylate (110): 
To a solution of (4aRS,5aRS,8aRS)-tert-butyl 3-benzamido-4a-(2-
fluorophenyl)-4a,5,5a,6-tetrahydro-1H-pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]oxazine-
7(8H)-carboxylate (111 mg, 238 µmol, equiv: 1.0) in MeOH (1.17 mL), K2CO3 (98.9 
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mg, 715 µmol, equiv: 3.0) was added. The mixture was stirred at 
50 °C during 4 hours. The reaction was washed with DCM/H2O. 
The organic layers were collected and dried over Na2SO4. All 
volatiles were removed under vacuum. The crude material was 
purified by flash chromatography (silica gel, 12 g, 0% to 100% 
EtOAc in heptane). The column was washed with 
DCM/NH3/MeOH to remove the product (4aRS,5aRS,8aRS)-tert-butyl 3-amino-4a-
(2-fluorophenyl)-4a,5,5a,6-tetrahydro-1H-pyrrolo[3',4':2,3]cyclobuta[1,2-
d][1,3]oxazine-7(8H)-carboxylate (67 mg, 78% yield) as a light yellow oil. 
1H NMR (600 MHz, DMSO) δ ppm 1.10 - 1.44 (m, 10 H) 2.11 - 2.42 (m, 2 H) 2.78 - 
2.97 (m, 2 H) 3.10 - 3.24 (m, 2 H) 3.41 (br d, J=11.2 Hz, 1 H) 3.47 - 3.61 (m, 1 H) 
4.06 - 4.36 (m, 2 H) 5.98 - 6.73 (m, 2 H) 7.02 - 7.58 (m, 4 H) 
LC/MS (ESI) m/z =362.187 [M+H]+ calculated from C19H24FN3O3 (M=361.180) 
 (4aSR,5aRS,8aRS)-tert-butyl 3-amino-4a-(2-fluorophenyl)-4a,5,5a,6-tetrahydro-
1H-pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]thiazine-7(8H)-carboxylate (109): 
To a solution of (4aSR,5aRS,8aRS)-tert-butyl 3-
benzamido-4a-(2-fluorophenyl)-4a,5,5a,6-tetrahydro-1H-
pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]thiazine-7(8H)-carboxylate 
(95 mg, 197 µmol, equiv: 1) in MeOH (1 mL), K2CO3 (81.8 mg, 
592 µmol, equiv: 3) was added. The mixture was stirred at 50 
°C during 2 hours. The reaction was washed with DCM/H2O. 
The organic layers were collected and dried over Na2SO4. All volatiles were removed 
under vacuum. The crude material was purified by flash chromatography (silica gel, 
12 g, 0% to 100% EtOAc in heptane). After some fractions come off the column with 
100% EtOAc, the column was washed with DCM/NH3/MeOH to remove extra 
product. After analytics (LC/MS and 1H NMR) the fraction from the rack and of the 
washed column were combined to give (4aSR,5aRS,8aRS)-tert-butyl 3-amino-4a-(2-
fluorophenyl)-4a,5,5a,6-tetrahydro-1H-pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]thiazine-
7(8H)-carboxylate (42 mg, 56.4 % yield) as a white solid. 
1H NMR (600 MHz, DMSO) δ ppm 1.11 - 1.34 (m, 9 H) 2.80 - 2.85 (m, 1 H) 2.83 - 
2.89 (m, 1 H) 2.86 (br s, 1 H) 3.13 (br s, 1 H) 3.12 - 3.17 (m, 1 H) 3.32 - 3.50 (m, 3 H) 
7.00 - 7.19 (m, 1 H) 7.07 - 7.13 (m, 1 H) 7.28 (br s, 2 H) 
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HRMS m/z =378.1656 [M+H]+ calculated from C19H24FN3O2S (M=377.1581) 
(4aRS,5aRS,8aRS)-4a-(2-Fluorophenyl)-4a,5,5a,6,7,8-hexahydro-1H-
pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]oxazin-3-amine dihydrochloride (112): 
 Suspend (4aR,5aR,8aR)-tert-butyl 3-amino-4a-(2-
fluorophenyl)-4a,5,5a,6-tetrahydro-1H-
pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]oxazine-7(8H)-
carboxylate (50 mg, 138 µmol, equiv: 1.0) in a solution of HCl 
(in dioxane) (138 µl, 553 µmol, equiv: 4.0) and triturate during 
2 hours, still starting material in the LC/MS, another equivalent 
of HCl (in dioxane) (138 µl, 553 µmol, equiv: 4) was added. 2 hours later the reaction 
was filterted and washed with diethyl ether, crystals highly hygroscopic. 
(4aRS,5aRS,8aRS)-4a-(2-fluorophenyl)-4a,5,5a,6,7,8-hexahydro-1H-
pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]oxazin-3-amine dihydrochloride (22 mg, 48% 
yield) as an off-white crystalline material was collected.  
1H NMR (600 MHz, DMSO) δ ppm 2.45 (dd, J=13.1, 8.7 Hz, 1 H) 2.96 (br d, J=9.3 
Hz, 1 H) 3.07 (br dd, J=13.2, 8.2 Hz, 1 H) 3.10 - 3.21 (m, 1 H) 3.31 (br dd, J=4.5, 2.3 
Hz, 1 H) 3.36 - 3.40 (m, 1 H) 4.48 (br d, J=12.1 Hz, 1 H) 4.75 (dd, J=12.1, 3.7 Hz, 1 
H) 7.24 - 7.38 (m, 2 H) 7.47 (br t, J=7.2 Hz, 1 H) 7.50 - 7.58 (m, 1 H) 7.89 - 9.26 (m, 
2 H) 9.76 - 10.35 (m, 2 H) 10.58 (s, 1 H) 
HRMS m/z=262.1370 [M+H]+ calculated from C14H16FN3O (M=261.1295) 
(4aSR,5aRS,8aRS)-4a-(2-Fluorophenyl)-4a,5,5a,6,7,8-hexahydro-1H-
pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]thiazin-3-amine dihydrochloride (111) 
 Suspend (4aSR,5aRS,8aRS)-tert-butyl 3-amino-4a-(2-
fluorophenyl)-4a,5,5a,6-tetrahydro-1H-
pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]thiazine-7(8H)-carboxylate 
(33 mg, 87.4 µmol, equiv: 1.0) in a solution of HCl (in dioxane) 
(87.4 µl, 350 µmol, equiv: 4.0) with the help of drops of THF and 
triturate during 2 h. After 2 h the LC/MS did not showed any 
conversion (no precipitation was verified) HCl (in dioxane) (87.4 µl, 350 µmol, equiv: 
4.0) was added and the reaction left to stir over night. Checked by LC/MS no more 
starting material and the crystals were filtrated and washed with diethyl ether to 
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give(4aSR,5aRS,8aRS)-4a-(2-fluorophenyl)-4a,5,5a,6,7,8-hexahydro-1H-
pyrrolo[3',4':2,3]cyclobuta[1,2-d][1,3]thiazin-3-amine dihydrochloride (17 mg, 56% 
yield) as an off-white crystaline material. 
1H NMR (600 MHz, DMSO) δ ppm 1.10 - 1.36 (m, 3 H) 2.82 (br dd,J=13.0, 6.1 Hz, 1 
H) 2.97 - 3.16 (m, 2 H) 3.41 - 3.53 (m, 2 H) 7.28 - 7.38 (m, 2 H) 7.49 (br t,J=7.5 Hz, 1 
H) 7.52 - 7.59 (m, 1 H) 8.33 (br s, 1 H) 9.22 - 10.22 (m, 2 H) 10.50 - 10.94 (m, 1 H) 
HRMS m/z =278.1126 [M+H]+ calculated from C14H16FN3S (M=277.1053) 
BACE1 & BACE2 Enzyme Assay. Enzyme inhibition assays were performed in 
384-well microtiter plates (black with clear bottom, non-binding surface from Corning, 
Cat. No.: 3655) in a final volume of 51 µl. Test compounds dissolved in DMSO at a 
concentration of 10mM were serially diluted in DMSO (15 concentrations, 1/3 dilution 
steps, final concentration range: 200-0.0004 µM). 1 µl of diluted compounds were 
mixed with 40 µl of enzyme on an H&P Teleshaker for 4 min. After addition of the 
MR121-labelled substrate, the plates were again strongly shaken for 2 min. The 
enzymatic reaction was followed by reading the fluorescence emission on a plate: 
vision reader (Perkin-Elmer) (excitation wavelength: 630 nm; emission: 695 nm) for at 
least 30 min in a kinetic measurement detecting an increase of MR121 fluorescence 
following the cutting of the quenched substrate. The slope in the linear range of the 
kinetic was calculated and the IC50 of the test compounds were determined using a 
four parameter Hill equation for curve fitting on the calculated %-inhibition values 
referenced to wells without enzyme and wells with enzyme but no test compound 
respectively. BACE1 enzyme used in the assay was prepared and purified as 
described.58The preparation of BACE2 was carried out following exactly the known 
protocol.46 BACE1/2 assay: The final enzyme concentration in the assay was 30 and 
125 nM respectively. The assay buffer was 100 mM sodium acetate, 20 mM EDTA, 
0.05 % BSA, pH 4.0. The substrate peptide was of sequivuence WSEVNLDAEFRC-
MR121 and used at a final concentration of 300 nM.11 
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